Intensity Modulated Proton Therapy Optimization Under Uncertainty: Field Misalignment and Internal Organ Motion by Liao, Li
Intensity Modulated Proton Therapy Optimization Under
Uncertainty: Field Misalignment and Internal Organ Motion
A Dissertation
Presented to
the Faculty of the Department of Industrial Engineering
University of Houston
In Partial Fulfillment
of the Requirements for the Degree
Doctor of Philosophy
in Industrial Engineering
by
Li Liao
December 2016
Intensity Modulated Proton Therapy Optimization Under
Uncertainty: Field Misalignment and Internal Organ Motion
Li Liao
Approved:
Chair of the Committee
Gino Lim, Professor,
Industrial Engineering
Committee Members:
Qianmei Feng, Associate Professor,
Industrial Engineering
Jiming Peng, Associate Professor,
Industrial Engineering
Xiaodong Zhang, Associate Professor,
Radiation Physics, The University of
Texas MD Anderson Cancer Center
X.Ronald Zhu, Professor,
Radiation Physics, The University of
Texas MD Anderson Cancer Center
Suresh K. Khator, Associate Dean,
Cullen College of Engineering
Gino Lim, Professor and
Chair, Industrial Engineering
Acknowledgements
First and foremost I would like to express my deepest appreciation to my advisor
Professor Dr. Gino Lim. His advice on both research as well as on my career has been
priceless. Without his guidance and persistent help, this dissertation would not have
been possible. I especially would like to thank Dr. Xaiodong Zhang (Department
of Radiation Physics, The University of Texas MD Anderson Cancer Center) for
providing me the opportunity to work in the greatest groups at the best cancer
hospital. His knowledge and insight inspired and motivated me.
Many thanks to Dr. Qianmei Feng, Dr. Jiming Peng and Dr. X.Ronald Zhu for
serving as my committee members. Thanks for their time, insightful suggestions and
providing valuable comments that improved the contents of the work.
I would also like to thank all the faculties, staff and friends who have contributed
immensely to my work and life at the University of Houston.
A special thanks to my family. Words cannot express how grateful I am to my
mother and parents-in-law for all of the sacrifices that they’ve made on my behalf.
Lastly, I would like express appreciation to my beloved wife Ting who spent sleepless
nights with and was always my support. Their support made me devote my time to
completing my Ph.D. study. This dissertation is dedicated to them.
iv
Intensity Modulated Proton Therapy Optimization Under
Uncertainty: Field Misalignment and Internal Organ Motion
An Abstract
of a
Dissertation
Presented to
the Faculty of the Department of Industrial Engineering
University of Houston
In Partial Fulfillment
of the Requirements for the Degree
Doctor of Philosophy
in Industrial Engineering
by
Li Liao
December 2016
v
Abstract
Intensity modulated proton therapy (IMPT) is one of the most advanced forms
of radiation therapy, which can deliver a highly conformal dose to the tumor while
sparing the dose in healthy tissues. Compared to conventional photon-based radiation
therapy, IMPT is more flexible in delivering radiation dose according to different
tumor shapes. However, this flexibility also makes the optimization problems in IMPT
harder to solve, e.g., it requires larger memory to store data and longer computational
time. Furthermore, proton beams are very sensitive to different uncertainties, such as
setup uncertainty, range uncertainty and internal organ motion. These uncertainties
can greatly impact the quality of clinical treatment. Therefore, this dissertation aims
to investigate different optimization methods for treatment planning and to handle a
variety of uncertainties in IMPT.
First,to solve the fluence map optimization (FMO) problem in IMPT, we propose
a method to formulate the FMO problem into a molecular dynamics model. So
that, the FMO problem can be optimized according classical dynamics system. This
method combines the advantages of gradient-based algorithms and heuristic search
algorithms.
Next, we develop and validate a robust optimization method for IMPT treatment
plans with multi-isocenter large fields to overcome the dose inhomogeneity problem
caused by the setup misalignment in field junctions. Numerical results show that the
robust optimized IMPT plans create a low gradient field radiation dose in the junction
regions, which can minimize the impact from misalignment uncertainty. Compare to
conventional techniques, the robust optimization method leads the whole treatment
much more efficient.
Lastly, we focus on a two-stage method to solve the beam angle optimization
(BAO) problem in IMPT with internal organ motion uncertainty. In the first stage,
a p-median algorithm is developed for beam angle clustering. In the second stage, a
vi
bi-level search algorithm is used to find the final beam angle set for the treatment.
Furthermore, Support vector machine (SVM) is used for beam angle classification to
reduce the search space and the 4D-CT information is incorporated to handle the
internal organ motion uncertainty. Results show that the two-stage BAO method
consistently finds a high-quality solution in a short time.
vii
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Chapter 1
Introduction
1.1 Background
Cancer is a fatal disease that accounts for nearly one fourth of total deaths in the
United States. A total of 1,658,210 new cancer cases are estimated to be diagnosed
and 595,690 cancer deaths in the United States in 2016 [1]. There are different types
of cancer treatment, such as surgery, chemotherapy and radiation therapy.
Radiation therapy: Radiation therapy is one of the most common treatments for
many types of cancer. About 60% of cancer cases receive radiation therapy during
their treatment [2]. Radiation therapy uses controlled high-energy radiation to dam-
age cancer cells’ DNA and destroy their ability to divide and grow. Abnormal cancer
cells are more sensitive to radiation because they divide more quickly than normal
cells. Over time, the abnormal cells die and the tumor shrinks. Since radiation can
damage both cancer cells and healthy cells, the goal of radiation therapy is to deliver
a prescribed dose of radiation to the tumor in order to kill or control the growth of
cancerous cells, while avoiding the delivery of excessive doses of radiation to surround-
ing critical organs and healthy tissues. According to the type and stage of cancer,
radiation therapy is used both as a stand-alone treatment and in combination with
other cancer treatments such as surgery and chemotherapy.
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There are two ways to deliver radiation: external beam radiation and internal
radiation (brachytherapy). External beam radiation is delivered from outside the
body by using a machine to aim high energy rays at the tumor. Different types of
radiation are used for external beam therapy, such as x-ray, gamma rays, photons and
proton beams. External beam therapy is the radiation therapy treatment option used
for most cancer patients. Internal radiation (brachytherapy) is delivered from inside
the body by placing radiation sources close to or inside the tumor. The radioactive
sources or isotopes are in the form of wires, seeds (or molds), or rods.
Treatment planning: To ensure the patients can get the full benefit from radiation
therapy while minimizing the impact on healthy organs, a careful planning is critical
before treatment. The main steps of radiation treatment planning can be described
as follows. In the beginning, the patients will be positioned carefully to keep the same
position during every treatment. To stabilize the position, a variety of immobilization
devices may be used, e.g., for a specific patient, a foam box shaped to patient form
will be used to keep the body position; a thermoplastic mask may be designed to
hold the patient’s head in place. Then, the computed tomography (CT) images of
the area of treatment will be taken to identify the internal structures of interest.
Sometimes, the other image techniques such as magnetic resonance imaging (MRI)
and positron emission tomography (PET) are also used to get more precise images to
identify the structures. After images are taken, a physician will delineate the target
tumor and the surrounding critical organs, also referred to as organs-at-risk (OARs),
which desire to spare. Along with the contour of these structures, the physician will
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also prescribe objective doses to the target volumes and constraints to OARs. The
treatment planner will base on all of these information to generate a treatment plan
to the patient.
Typically, the whole radiation therapy treatment is divided into many treatment
sessions, known as "fractions", with daily intervals or breaks for the weekend. One
small portion of total prescribed radiation dose is to be delivered in each fraction. The
whole treatment may last for 4 to 6 weeks. The reason of fractionation is based on
the radiobiological effects of the dose on the healthy and cancerous cells. Compare to
healthy cells, the cancer cells generally have much less ability to repair DNA damages
caused by radiation exposure. Therefore, by splitting the dose to many treatment
fractions, the healthy cells can repair the damage and recover between treatment
fractions, but the accumulated radiation dose can lead to lethal damages to tumor
cells. This mechanism enables patients to tolerant a higher total radiation dose to
expect a better treatment outcome.
Generally, there are two types of radiation treatment planning process: for-
ward planning and inverse planning. Forward planning is often applied for three-
dimensional conformal radiation therapy (3DCRT) and passive scattering proton
therapy (PSPT). In which, treatment planner specifies the directions, shapes and
intensity of the beams then calculate and evaluate the plan quality. If the plan is
not meet the clinical requirements, the planner repeats the process until the require-
ments are satisfied. The whole process of forward planning is very tedious and time
consuming, and the quality of treatment plan highly depends on the experience of
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the treatment planner. Due to the new technology development, radiation therapy
delivery modalities become more flexible and precise, such as intensity modulated
radiation therapy (IMRT) and intensity modulated proton therapy (IMPT). In these
radiation treatment plans, there are much more parameters need to consider dur-
ing the planning. The forward planning process is not applicable anymore. Instead,
a variety of optimization models were developed to solve the problems for different
radiation treatment delivery modalities. Planner specifies the desired requirement,
such as a prescribed dose of the tumor, max tolerance of OARs into the model, the
optimization algorithms will try to determine all the parameters to achieve the re-
quirements as good as possible. This type of treatment planning is called inverse
planning. In this thesis, we focus on inverse treatment planning.
Intensity Modulated Proton Therapy: After decades of development, the pro-
ton therapy is widely adopted to treat cancer patients over the world. Compare to
conventional photon-based radiotherapy, proton therapy uses charged proton beams
that have a very attractive physical characteristics for radiation therapy (see Figure
1.1). First, the deposited dose of a proton beam starts from a low entrance level, its
energy increases gradually while increasing depth, then suddenly jumps to a sharp
peak known as the Bragg peak. Once the dose deposition reaches a few millimeters
beyond this peak, it falls sharply to zero. Therefore, proton beams may deliver nearly
no dose to regions beyond the target, which is typically not feasible for photon beams.
Second, the depth of the Bragg peak can be controlled by alteration of the energy of
the incident protons. This amounts to an additional degree of freedom as compared
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to photon therapy. The superposition of pencil beams of different energies allows for
spread-out Bragg peaks that cover the full target volume in depth. So, protons ther-
apy can achieve a more conformal high dose to the tumor regions and a better dose
sparing to the normal tissue region than photon-based radiation therapy modalities.
Figure 1.1: Depth-dose curves of a photon beam (red), a proton spread-out Bragg peak
(blue, thick), and the proton pencil beams constituting the spread-out Bragg
peak (blue, thin).
In proton therapy, a particle accelerator is used to deliver a beam of protons to
the tumor. Currently, the passive scattering proton therapy (PSPT) and intensity
modulated proton therapy (IMPT) or pencil beam scanning are two available proton
beam delivery modalities. In PSPT, the proton beam is spread by placing scattering
material into the beam path and shaped by aperture and compensator (Figure 1.2b).
In IMPT, the proton beams are delivered as narrow scanning pencil beams, also called
beamlets. The tumor target volume is divided into multiple scanning spots (Figure
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1.2a). These three-dimensional (3D) arrangement of scanning spots is achieved by
controlling the energy level of the proton beamlet (determining the depth of a spot
from patient surface) and the intensity scanning magnets (determining the lateral
position of a spot). Beamlets with the same energy level (or depth) are located in one
layer, often called the energy layer. The intensity of a beamlet, i.e., beamlet weight, is
controlled by the exposure time. A higher intensity of a beamlet, i.e., longer beam on
time, results in a higher radiation dose deposited on a specific spot. So, compare to
PSPT, IMPT is more flexible to generate dose distribution according to the different
shape of tumors.
Figure 1.2: Proton pencil beam scanning (a) and passive scattering proton therapy (b)
Evaluation of treatment plan quality: The primary method to evaluate the
quality of a radiation treatment plan is to analyze the resulting dose distribution
associated with anatomical images. The test can be performed by checking 2D or 3D
dose distribution to evaluate if coverage of target is actually adequate; or by verifying
the mean dose or point dose of critical organs to assure the healthy tissue are well
protected.
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In treatment planning, dose volume histogram (DVH) is an important tool to
evaluate the plan quality [3]. Many important dose distribution indices of a region of
interest (ROI) can be easily evaluated by inspection of its cumulative DVH. DVH is
also a valuable tool for treatment plan comparison for a specific patient. Examples
of DVHs are shown in Figure 1.3.
Figure 1.3: Example of DVHs
In DVH, the Dv is represent the dose level d, such that a given v% volume of an
ROI receives d Gy or higher dose and Vd is represent the percent of the volume of an
ROI v%, such that v% volume of an ROI receives a given d Gy or higher dose. There
are some DVH indices that commonly used to evaluate plan quality, e.g., D100 and D0
are used to present minimum and maximum dose; D50 is a median dose of ROI. Based
on DVH, people also derived some useful indices, such as homogeneity index which
equals (D5-D95)/Dmean, and the ratio between the patient volume that receives 95%
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of the prescription and the target volume used as conformity index [4]. DVH values
also used as input data to predict the biological outcome from radiation therapy.
For example, the tumor control probability (TCP) and normal tissue complication
probability (NTCP) [5, 6]. TCP stands the probability that a given radiation dose
will kill or control the tumor cells and NTCP stands the probability that an organ
or structure to have a complication with a given dose of radiation. Note that many
of the parameters of TCP and NTCP models, and in fact, the models themselves,
are still under investigation, and may be the subject of significant controversy. In
addition, DVH clusters and band graph which consist of a group of DVHs in a variety
of are always used to evaluate the impact of uncertainties to the radiation treatment
plans.
1.2 Problem Statement
In radiation therapy, the fundamental goal is to deliver a prescribed dose to cover
the target while sparing radiation on the surrounding OARs. These two goals are in-
herently contradictory if the targets and critical structures are near each other or
overlapping. So, the whole treatment planning can be considered as an optimization
problem of balancing these two objectives. In IMPT, different procedures of treat-
ment planning can be formulated as different sub-problems. Generally, the beam
angle optimization (BAO) and the fluence map optimization (FMO) are two major
optimization problems in IMPT treatment planning.
Since the radiation would damage healthy cells in OARs which located along
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the path of the external beam. To avoid the radiation dose deposition in the OARs
exceeds its tolerance, treatment plans are always designed to deliver radiation from a
number of different angles around the patient. Multiple beams also can lead a more
uniform dose coverage on tumor than a single beam. So, selection of suitable beams
is critical to making a high quality treatment plan. The problem of choosing beam
angle is called beam angle optimization problem. However, the beam angle selection
is typically a large-scale combinatorial optimization problem and the whole process
can be very time consuming. In clinical practice, the beam angle selection is still
based on the treatment planner’s experience and intuition. So, efficient methods for
BAO is an important topic and still under investigation.
In IMPT, a beam of radiation consists of thousands of beamlets, each one has an
independently adjustable intensity. The intensity map of all beamlets from all beam
directions is also called fluence map. The problem of adjusting beamlets intensity
profiles to ensure the treatment plan can deliver the radiation to the tumor and
avoid neighboring critical structures is fluence map optimization (FMO) problem.
In this problem, the beamlets intensities are the decision variables. Due to a large
number of decision variables, the FMO problem is always solved by computers. So,
the final result quality directly relies on the mathematic models and the optimization
approaches.
Uncertainty issue in radiation therapy: During radiation treatment process,
many uncertainties can come from different procedures of radiation treatment process.
These uncertainties can be classified as follows:
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• Setup error: this error is due to the misalignment of incident beams and the
patient anatomy during day to day treatment.
• Range error: range error arises from multiple sources, such as CT image error,
CT number to stopping power conversion error, patient gain or loss weight and
tumor shrinkage.
• Intrafractional organ motion: This error is caused by the internal motion of
organs and tissues in a human body during a treatment session. For example,
in the proton therapy of lung cancer and esophageal cancer, the respiratory
motion may cause significant changes in patient geometry.
Since treatment plans are designed based on the planning CT images and as-
sumed to be identical with the patient geometry during the treatment. So, all the
uncertainties mentioned above may cause the delivered dose to seriously deviate from
the planned dose distribution and lead to some unforeseen results. To reduce the un-
certainties in radiation therapy, different strategies have been proposed and applied
in clinical treatment.
The combination of imaging and immobilization devices have been commonly
used to detect and mitigate setup errors [7, 8, 9, 10, 11]. Gating and breath holding
techniques are used to reduce the impact of respiratory motion [12, 13, 14, 15]. How-
ever, all these methods require extra devices and usually technologically demanding
and may extend the treatment time.
In conventional photon-based radiotherapy (e.g., IMRT and 3DCRT), the un-
certainties can be accounted by adding margins, i.e., a margin added around to the
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clinical target volume (CTV) to form a planning target volume (PTV) to ensure
CTV can receive the prescribed dose in the presence of uncertainties. The margin ap-
proach works well in conventional photon-based therapy, due to the static dose cloud
approximation, i.e., photon dose is robust to the anatomy change on the beam path
[16]. However, compare to photon-based radiation therapy, proton therapy is even
more vulnerable to the uncertainties. Because of the physical character of the proton
beam, the position of the Bragg peak is highly sensitive to the traversed medium
on proton beam path. Combined with proton pencil beams can shape very accurate
dose with a sharp gradient. The geometric changes may cause significant deforma-
tion of the proton dose distribution (Figure 1.4), especially for the case with large
internal motion such as lung cancer and esophageal cancer. To handle the complex
Figure 1.4: The distortion of proton dose distribution in the lung with respiratory motion.
(a) planned dose distribution. (b) dose distribution of the same spots with
respiratory motion.
uncertainties in radiation therapy, robust optimization is introduced to incorporate
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different errors into the optimization process to improve the robustness of treatment
plans. Many robust optimization models for photon-based radiation treatment plan-
ning were developed by researchers. Worst case based and probabilistic based robust
optimization methods are the two major groups used to describe the uncertainties
in radiation therapy. Either linear programming (LP) or non-linear programming
(NLP) model can be used to handle this problem. Different researchers also reported
using robust optimization to handle different uncertainties [17, 18, 19, 20, 21]. Due
to the proton beam is sensitive to uncertainties, the robust optimization for IMPT
treatment planning is even more critical.
1.3 Objectives & Contributions
This dissertation aims to develop new methodologies to handle the complex
problems (fluence map optimization, uncertainty issue and beam angle optimization)
in intensity modulated proton therapy treatment planning. The contributions of this
dissertation research are listed as follows:
• Objective 1: We develop a molecular dynamics method for solving the FMO
problem in intensity modulated proton therapy. This method combines the ad-
vantages of global and local search algorithms to overcome the local entrapment
issue observed in many gradient-based algorithms that are extensively used in
radiotherapy planning systems in clinics. This approach is a good alternative
method of gradient-based algorithms to solve the FMO problem and consistently
produces high-quality treatment solution in a clinically required time frame.
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• Objective 2: Conventional treatment planning process for multi-isocenter large
field patient case is a complex process. To improve the efficiency of treatment
planning for these cases, we propose a new robust optimization approach to
handle the uncertainty issue in IMPT treatment planning of the multi-isocenter
large field patient case. The robust optimized IMPT plans can incorporate filed
misalignment uncertainty in the treatment process. As a result, it can easily
generate low gradient field dose in the junction region to minimize the dose
deviation of uncertainties. This approach can greatly reduce the complexity of
treatment planning for the multi-isocenter large field patient case.
• Objective 3: Requiring excessive amount of time and easily trapping in local
minimum are the main drawbacks of conventional beam angle optimization al-
gorithms. To overcome these problems, we investigate a two-stage robust beam
angle optimization method in IMPT treatment planning for thoracic cancer.
We explore the prior knowledge from dose deposition information to develop a
beam angle score function to evaluate the merit of beam angles to guide the
beam angle selection. Clustering technique is utilized to group beam angles
and shrink beam angle search space. We designed a bi-level local neighborhood
search algorithm to search the final beam angle set for the treatment. Sup-
port vector machine is also used in to reduce the search space. This algorithm
provides consistent high quality solutions and outperforms other methods in
computational time.
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1.5 Organization
This dissertation is organized as follows. Chapter 2 provides a comprehensive
literature review for the related research on 1) the optimization methods for the
fluence map optimization problem, 2) uncertainty problem of intensity modulated
proton therapy and the related robust optimization methods 3) beam angle optimiza-
tion of radiation therapy. In Chapter 3, we present a molecular dynamics method for
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solving the fluence map optimization problem in intensity modulated proton therapy.
Compare to conventional gradient based method which may yield different results
when starting with different initial points, the molecular dynamics method can con-
sistently produce solutions that are the same or within a negligible margin of error
regardless of the initial conditions used. In Chapter 4, we propose and validate a
robust optimization approach for multi-isocenter large field treatment plan using in-
tensity modulated proton therapy to overcome the dose inhomogeneity caused by
field misalignment in the junction regions. Results show that the robust IMPT can
deliver a low gradient field dose in the junction which can minimize the dose deviation
caused by misalignment. We also present the relationship between dose deviation,
uncertainty and junction size. In Chapter 5, we focus on beam angle optimization
problem in IMPT treatment planning. A two-stage method is developed to solve the
BAO problem incorporating internal organ motion for thoracic cancer using IMPT.
The first stage of the method is beam angle clustering and the second stage is final
solution searching. Support vector machine is used for beam angle classification and
4D-CT is integrated to handle internal organ motion. Finally, Chapter 6 is devoted
to making a summary and discuss some potential research directions following this
dissertation.
17
Chapter 2
Literature Review
2.1 Fluence Map Optimization Problem
The fluence map optimization problem is a basic topic for radiation treatment
planning optimization. The goal is to select an optimal intensity map of beamlets
to deliver a uniform prescribed dose to the target while minimize the radiation dose
on critical organs. To accomplish this, an objective function is used to describe the
difference between the desired dose distribution and the realized dose distribution.
Different formulations have been proposed in previous studies.
The most commonly used objective functions are dose based and dose-volume
based objective functions [22, 23, 24, 25]. The advantage of these objective functions
is they are straightforward for the treatment plan evaluation. [26] proposed an ob-
jective function based on the equivalent uniform dose (EUD) for radiation therapy
optimization. This objective function uses the biologically equivalent dose to evaluate
the plan quality. Linear programming models also have been used to formulate the
FMO problem [27].
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In order to solve the fluence map optimization problem a great number of opti-
mization algorithms have been proposed to find the optimal beamlets intensity pro-
files. These strategies can be grossly classified into two groups: global optimiza-
tion (GO) and local optimization (LO). GO approaches include linear programming
[27, 28, 29], mixed integer programming [30, 31], simulated annealing [32] and ge-
netic algorithms [33, 28]. These approaches are designed to reach a global optimal
solution. However, they all require an excessive amount of time for optimization,
which is not practical in clinical treatment planning. In addition, the performance
of these approaches depends heavily on the choice of parameters [29]. For example,
simulated annealing and genetic algorithms, have the advantages of avoiding getting
trapped in local minima in principle, they are slow and may also get trapped in local
minima if the thermal cooling process is too fast in the case of simulated annealing,
or if the population evolution is not realistic in the case of genetic algorithms. Linear
programming methods can incorporate constraints and guarantee to have an optimal
solution. However, they are limited to linear objective functions, which are poor indi-
cators of the response of tumors and healthy tissue to radiation. On the other hand,
LO approaches include gradient-based algorithms [34, 35, 36, 37], local neighborhood
search [38] and iterative methods [39]. These algorithms are designed to find a local
minimum solution in a relatively short time. So, LO approaches have been com-
monly used for clinical treatment planning optimization to yield a clinical acceptable
solution within a clinical acceptable time frame. Especially, the gradient-based algo-
rithms approaches have been chosen for commercial treatment planning systems such
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as Eclipse [Varian Associates, Palo Alto, CA] using quasi-Newton method [40] and
sequential quadratic programming (SQP) employed in Pinnacle [Philips, Milpitas,
CA].
2.2 Robust Optimization for Radiation Therapy
In standard radiation treatment regime, the spatial and temporal dose distribu-
tion is optimized assuming the patient geometry is static over the course of treatment
and a fixed dose of radiation is delivered in every treatment fraction. However, during
the course of treatment, the patient geometry may deviate from the one observed in
the image on which a treatment plan is based. These uncertainties add complexity
to the inherent trade-off between minimizing the healthy tissue dose (or probability
of side effects) and ensuring that the tumor receives a sufficient dosage of radiation.
To date, robust optimization is widely used to incorporate different uncertainties
into the optimization process to improve the robustness of treatment plans. Many
robust optimization models for radiation treatment planning were developed by re-
searchers. [18] proposed a robust optimization approach accounted for patient in-
terfraction motion and setup uncertainties for IMRT. The results demonstrated that
robust solution achieved better healthy tissue sparing than a clinical margin solution
without compromising tumor coverage and robustness. [19] considered dose matri-
ces calculation error and interfraction position uncertainties into an IMRT treatment
planning problem formulation, and showed that a robust solution outperforms nomi-
nal solution (one which assumes a dose matrix in known with certainty) in terms of
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tumor coverage and improved healthy tissue sparing when compared with margin solu-
tion. [17] use a three-dimensional Gaussian distribution function to simulate random
organ motion for IMRT planning. [21] introduced a robust methodology for IMRT
treatment planning under uncertainty and considered the specific case of intrafrac-
tional uncertainty induced by breathing motion. They incorporated the uncertainty
in the probability mass function of breathing motion into the inverse planning opti-
mization and ensured that all target voxels received sufficient expected dose for all
probability distributions within a polyhedral set. [41] generalized robust optimiza-
tion framework for IMRT planning without considering probability distribution of
uncertainties.
Worst case robust optimization is another main approach to consider uncertain-
ties. [37] proposed a "worst case" optimization method for IMPT by considering both
setup uncertainty and range uncertainty. In this approach, the worst case dose in
each voxel was calculated to evaluate the objective function. [42] use minimax robust
optimization method to handle setup and range uncertainties in IMPT planning. The
worst scenario among the nominal and uncertainty cases was punished by the opti-
mization algorithm. Both of these approaches can work with a linear programming
(LP) model [43] and a nonlinear programming (NLP) model [44]. The results of all
these papers show that the robustness of IMPT plan can be significantly improved
by robust optimization, while without loss nominal case target coverage and OAR
sparring.
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2.3 Beam Angle Optimization Problem
In radiation therapy, to ensure a uniform target dose coverage and to avoid
the radiation dose deposition in the OARs exceed its tolerance, treatment plans are
always designed to deliver radiation from a number of different angles around the
patient. So, the beam angles selection is critical to making a high-quality treatment
plan. However, the beam angle optimization (BAO) problem in radiation treatment
planning is typically a large-scale combinatorial optimization problem. Due to the
computational difficulty, BAO is not implemented in commercial treatment planning
systems (TPS). In the current clinical practice, the number and angles of treatment
beams are decided heavily based on the knowledge and experience of planners. To
achieve the automated selection of the orientations of treatment beams for external
radiation therapy, different studies have extensively investigated optimization algo-
rithms for solving the BAO problem. These strategies can be mainly classified into
two groups.
The first group algorithms combine beam angle selection and fluence map op-
timization to formulate the BAO problem as a mixed integer programming (MIP)
problem. [45] first proposed the MIP model for beam angle selection for the conven-
tional conformal radiation therapy. [46] introduced a MIP model to solve the BAO
for IMRT, which incorporated the FMO in IMRT to guide the beam selection. [47]
proposed a mixed integer linear programming technique for BAO for conventional
3D conformal radiation therapy and later [48] extended that work to IMRT opti-
mization. However, solving the BAO problem is computational intensive because it
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is typically a large-scale combinatorial optimization problem. Moreover, the BAO is
highly nonconvex and may have many local optima. To solve this problem within
a clinical acceptable computational time, different algorithms have been proposed.
[49] utilized a generic algorithm to optimize the beam angles for conventional con-
formal radiation therapy. [50] extended the research using GA for the IMRT beam
angle optimization. [51] proposed a particle swarm algorithm for BAO. Simulated
annealing and fast simulated annealing algorithms have also been used for beam an-
gle optimization [52, 53]. [54] also introduced an artificial neural network algorithm.
[55] developed a nested partition method and [56] introduced a neighborhood search
algorithm for BAO. [57] introduced a sampling strategy to reduce the size of the
problem to shorten the solution time. [38] proposed a two-phase method, which us-
ing a Branch and Prune (B&P) algorithm combine with a local neighborhood search
method to find solutions close to global optimal within a short time. Based on the
advantages of different algorithms, [58] introduced a hybrid framework to improve
the efficiency of BAO in IMRT. Although these algorithms may increase the speed of
solving BAO problem, they still require a large number of iterations and the results
are also influenced by initial points and the parameters choose for the algorithms.
The second class of solutions to BAO uses prior knowledge about the problem
to guide the beam angles selection to reduce the search space. [54] attempted an
intelligent search using an artificial neural network technique to evaluate geometric
data. [59] introduced scalar scoring functions to rand candidate beam directions by
using beam’s-eye-view projections technique. These pre-optimization lead to the set
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of treatment beams is assigned to the most favorable beam directions. [60] used a
measure of angle suitability based upon the beam’s-eye-view to select beams for both
coplanar (i.e., all beams with the same iso-center) and non-coplanar (i.e., beams with
different iso-centers) 3D conformal radiotherapy. [61, 62] neglect the beam selection
from a large combination MIP problem and choose to add beams to a radiation
therapy plan iteratively. [63] attempted a beam angle selection method based on
target equivalent uniform dose (EUD). [64] ranked the beam orientation based on
dose-volume information for IMRT beam selection. [65] reported a beam score method
for BAO. The score is determined by the maximum PTV dose delivery of each beamlet
and the overall score of the gantry angle was calculated as a sum of the scores of
all beamlets. [66] facilitated a clustering algorithm in the context of beam angle
selection by applying a Euclidean metric in a space of characteristic vectors for a set
of candidate beam directions. [67] suggested a spherical K-means clustering algorithm
for beam angle selection for IMRT.
Although the previously published algorithms showed the benefits of using BAO
to improve the treatment plan quality, while most previously published studies on
BAO were designated for conventional photon-based radiotherapy, algorithms intro-
duced might be difficult to hold their quality and efficiency in implementation for
IMPT. First, it is much more expensive to compute a score for an incident beam
configuration in IMPT planning than that in IMRT or 3DCRT because of larger data
size. The dose influence data for IMPT must contain information of scanning spot
depth which is an additional dimension beyond typical IMRT data. Another critical
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distinction is the plan robustness over delivery uncertainties in IMPT planning can
be critical which is usually absent in photon-based radiotherapy. As protons deliver
most of their dose at their Bragg peaks, misplaced Bragg peaks can easily cause dose
inhomogeneity in the target volume and overdosing in normal tissues. Therefore,
IMPT plan can be very sensitive to treatment delivery uncertainties. The final de-
livered dose distribution will greatly deviate from the prescribed dose if uncertainties
are not considered in the treatment planning process. The beam angle can be an
important fact for plan robustness, especially for the cancer cases with large organ
motion such as lung and esophageal cancer. The previous algorithms haven’t consid-
ered this information to perform the beam angle selection, so they may not able to
guarantee the plan quality and robustness to meet the clinical criteria at the same
time.
[43] introduced a method to incorporate the setup and range uncertainties in
a local neighborhood search algorithm to solve robust BAO problem. Although this
local search algorithm may increase the speed of solving BAO problem, it still requires
a large number of iterations and the results are influenced by initial points. Especially,
for uncertainty incorporated BAO, different dose scenarios need evaluation in each
iteration, an intensive computer time is still need. To increase the effectiveness of
solving robust BAO is important and still an open question in both the practice and
the research domain.
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Chapter 3
A Molecular Dynamics Method for
Fluence Map Optimization in Intensity
Modulated Proton Therapy
The fluence map optimization (FMO) problem of radiation therapy is commonly
formulated as a quadratic programming (QP) model with non-negativity bounds on
variables. Because the resulting QP model is very large scale, many researchers in
the medical community have proposed to convert the FMO problem into an uncon-
strained minimization model, and then used gradient-based optimization methods
such as quasi-Newton to solve the problem faster. However, there is a major issue
concerning the convergence of such approaches, claimed by many researchers, that
the model has multiple local optimal solutions; hence the quality of the solution varies
widely depending on an initial solution to the problem. This is contradictory to the
theory of a convex model. We believe that the actual issue is due to the removal of
non-negativity constraint in the model coupled with a poor implementation of the
algorithm. To shed the light on this problem and to make an initial attempt to
overcome such shortcomings, we propose a molecular dynamics (MD) method as a
new alternative for solving the QP model. A dose-based objective function is used
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to compare the performance of the MD method with those of the gradient based
methods using three clinical cancer cases: prostate, head-and-neck, and lung cancer.
Overall, the MD method consistently converged to a solution regardless of the initial
conditions as used by many researchers. Furthermore, MD converged faster than
L-BFGS-B that is more reliable algorithm than L-BFGS.
3.1 Introduction
The fluence map optimization (FMO) problem of intensity modulated radia-
tion therapy (IMRT) planning has been extensively studied and has been addressed
by various solution strategies, such as linear programming, simulated annealing, ge-
netic algorithms and gradient-based local search algorithms. In these algorithms,
the gradient-based local optimization approaches are normally adopted to solve the
FMO problem in clinical practice because they can yield a clinical acceptable solution
within a short frame.
Based on the physics of radiation particle transport, a feasible radiation treat-
ment plan must contain non-negative beamlet intensity. Nevertheless, researchers
in the medical community have often used unconstrained gradient-based algorithms
to optimize treatment plans [68, 69], as it is implemented in a leading commercial
treatment planning system such as Eclipse [Varian Associates, Palo Alto, CA]. This
has resulted in sub-optimality due to exclusion of the non-negative constraint, and
difficulty of convergence to a global optimal solution due to a poor implementation of
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the algorithm. To tackle this issue, these researchers replied on an unconstrained QP
model and commonly solved it using a gradient-based method with different starting
point generation strategies, which really did not resolve the fundamental issue of the
problem as we point out in this paper.
Despite the fact that many solution approaches have been proposed to solve the
FMO problem, a method of avoiding local minima while converging to a solution
within a practical time limit has rarely been reported. [70, 71] proposed a method
to formulate the IMRT FMO problem into a molecular dynamics problem which
motivated the study in this chapter. Molecular dynamics is a powerful computational
technique that is often used to simulate the physical movement of atoms and molecules
in a many-body system. In Hou’s paper, the beamlets in IMRT were considered as
virtual atoms. The weight of the beamlets were formulated as the positions of the
virtual atoms and the objective function value (OFV) of the FMO problem in IMRT
was formulated as the potential energy of the dynamic system. In classical molecular
dynamics, because the movement of atoms follows Newton’s Law of Motion, the
dynamic system will relax to an equilibrium state with the lowest free energy. In
this process, the position and velocity of the atoms will change with time. Thus,
following the MD formulation, the beamlets weight and virtual velocity will update
over time and the OFV of the FMO problem will be minimized. The MD method’s
feature of virtual velocity differs from traditional gradient algorithms in that it only
updates the weight. Furthermore, within the FMO problem, virtual velocity can help
atoms to keep in the bounded area, e.g., an atom goes out of the range but can move
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back by changing the direction of its velocity. In addition, the search direction in
MD follows dynamic equations which enable MD to converge faster than many global
optimization methods. To show the performance of MD, three well cited gradient
methods are selected and implemented for the IMPT FMO problem, and all four of
these methods are tested using three clinical cancer patient cases and the typical three
different starting point generation approaches used by many researchers in the medical
community. The primary objective of this study is to demonstrate that the MD
method can be a viable alternative for solving the IMPT FMO problem to overcome
the major issue of traditional gradient-based methods: a premature termination to a
feasible solution and sensitivity to the starting point to the algorithm.
The remainder of the paper is organized as followed: Section 3.2 describes the
optimization model and the solution algorithms for the FMO problem in IMPT,
which include gradient-based methods (an existing quasi-Newton method, L-BFGS
and L-BFGS-B) and the MD method. The data used in the experiment and the
initial configuration setups are listed in Section 3.3. Section 3.4 provides the results
and discussion regarding the convergence properties of the MD method and other
gradient algorithms.
3.2 Optimization Model and Solution Algorithms
3.2.1 FMO Problem Formulation
The main purpose of IMPT is to deliver the prescribed conformal radiation dose
to the targeted tumor while sparing normal tissues. To achieve this goal, we define
a quadratic objective function to quantify the difference between the prescribed dose
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(Dn , where n is the index of organ of interest) and the actual dose ( Di, where i is the
voxel index) delivered to the patient. Although different types of objective functions
are reported in the literature [72, 73], dose-based quadratic objective functions are
commonly used in the medical physics community [34, 35, 36, 44] for optimizing beam
intensities in radiation therapy. Hence, it is used to develop the optimization model
for this paper.
A dose-based objective function F is composed of two parts: F T for the target,
and FOAR for the OAR. Because the primary goal of treatment planning is to obtain
an actual radiation dose profile that is identical or nearly identical to the prescribed
dose level on the target, F T can be defined as the deviation of the resulting actual
dose Di on voxel i from the target prescription dose DT :
F T = 1
NT
NT∑
i=1
(
Di −DT
)2
, (3.1)
where NT is the total numbers of voxels in the target. Similarly, FOAR can be defined
as
FOAR = 1
NOAR
NOAR∑
i=1
(
Di −DOAR
)2
+
, (3.2)
where NOAR is the total number of voxels in the OAR, DOAR is the specified tolerance
dose for the organ, and (δ)+ is defined as (δ)+ = max (δ, 0). Note, we introduced the
step function FOAR because healthy organs are often allowed to receive radiation
doses up to a certain amount. However, once the amount is over a tolerance value, a
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penalty will be imposed on the voxel according to the degree of deviation from the
tolerance.
The dose Di in voxel i can be calculated as
Di =
N∑
j
kijωj, (3.3)
where ωj is the weight or intensity of beamlet j, which is the decision variable of our
IMPT optimization model. Notation N denotes the total number of beamlets and kij
is the unit dose contribution of the jth beamlet to the ith voxel; kij is also known as
the dose deposition coefficient. Here the values of kij are calculated using an in-house
dose calculation engine for proton beamlets [74].
Using the notation described above, the dose-based objective function for our
optimization model is
F =
∑
n
pTF T +
∑
m
pOARFOAR, (3.4)
where pT and pOAR denote the penalty weights of the tumor and OAR, respectively.
These weights are often obtained by trial and error by planners (dosimetrists, physi-
cists, etc.,), to find a balance between tumor dose coverage and OAR dose sparing
to satisfy the clinical criteria. In this study, the model follows the common practice
in the medical community of containing a physical constraint: the beamlet weight
cannot be negative, i.e., ωj ≥ 0, j = 1, 2...N . Hence, our optimization model for the
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IMPT FMO problem is
min F
s.t. wj ≥ 0 , j = 1, 2, · · · , N .
(3.5)
3.2.2 Solution Algorithms
The general nonlinear optimization algorithms updating function can be de-
scribed as
xk+1 = xk + αkdk, (3.6)
where the xk is the decision variables at the kth iteration, dk and αk are the cor-
responding direction and step size. The solution can be found using the following
iterative process:
(1) Calculate search direction dk and step size αk.
(2) Update the decision variables according to the updating function.
(3) Check whether the stopping criterion is satisfied. If it is not satisfied go to
step 1; otherwise, output the final solution.
Different algorithms are classified according to the way they choose the search
direction and the step size. We have selected three well-cited gradient based meth-
ods (a quasi-Newton method, L-BFGS and L-BFGS-B algorithms) to compare the
performance of the proposed MD method. Note that the quasi-Newton and L-BFGS
are unconstrained optimization algorithms and L-BFGS-B is designed to handle the
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problem with bound constraints.
A quasi-Newton method
For the standard Newton’s method, search direction dk is generated according
to the gradient and the Hessian matrix, dk = [∇2F (xk)]−1∇F (xk). Accordingly, the
updating function for the FMO problem can be described as
ω (k + 1) = ω (k)− αk ∇F (ω (k))∇2F (ω (k)) , (3.7)
where the first derivative of the objective function is
∂F
∂ωj
= 2 p
T
NT
NT∑
i=1
(
Di −DT
)
kij + 2
pOAR
NOAR
NOAR∑
i=1
(
Di −DOAR
)
kij, (3.8)
and second derivative is
∂2F
∂ωj∂ωk
= 2 p
T
NT
NT∑
i=1
kijkik + 2
pOAR
NOAR
NOAR∑
i=1
kijkik. (3.9)
The Newton’s method can be used for solving the FMO problem, but there are
inherent disadvantages: (1) the computation of the inverse of the Hessian matrix
may require extensive time because of the large size of the beamlet vector ω (k), and
(2) the Newton’s method is an unconstrained algorithm, which cannot guarantee the
feasibility of the solution to the treatment. To overcome these shortcomings, the
problem can be computed in a clinical acceptable time, we approximate the Hessian
matrix by its diagonal [34]. And we applied the damping factor which introduced by
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Lomax(1999) as step size αk to deal with the non-negativity constraints, which in the
form of:
aij (k) =
ωj (k) kij
Di (k)
. (3.10)
Therefore, the updating function of the beamlet weight ωj becomes
ωj (k + 1) = ωj (k)− αk
 ∂F∂ωj
∂2F
∂ω2
j

= ωj (k)
pT
NT
NT∑
i=1
k2ij
DT
Di
+ p
OAR
NOAR
NOAR∑
i=1
k2ij
DOAR
Di
pT
NT
NT∑
i=1
k2ij+
pOAR
NOAR
NOAR∑
i=1
k2ij
.
(3.11)
As a result, the ωj(k+1) equals to ωj(k) times a positive coefficient, which guarantees
the feasibility of non-negative beamlet intensities.
L-BFGS: Limited-memory Broyden-Fletcher-Goldfarb-Shanno algorithm
The major difference of an L-BFGS algorithm [75] compared to the quasi-Newton
method is in the updating function that can be described as
xk+1 = xk − αkHk∇f(xk), (3.12)
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where
Hk+1 = (V Tk · · ·V Tk−mˆ)H0(V Tk−mˆ · · ·V Tk )
+ ρk−mˆ(V Tk · · ·V Tk−mˆ+1)sk−mˆsTk−mˆ(V Tk−mˆ+1 · · ·V Tk )
+ ρk−mˆ+1(V Tk · · ·V Tk−mˆ+2)sk−mˆ+1sTk−mˆ+1(V Tk−mˆ+2 · · ·V Tk )
...
+ ρksksTk
, (3.13)
yk = ∇f(xk+1)−∇f(xk), (3.14)
ρk =
1
yTk sk
, and (3.15)
Vk = I − ρkyksTk . (3.16)
In Hk, the mˆ is the number of stored Hessian approximation correction steps and
the step size αk is selected to satisfy the Wolfe conditions. However, L-BFGS is
also an unconstrained algorithm. To handle the non-negativity issue, the beamlet
intensity ωj is often replaced by a non-negative quantity ω′j
2 [44, 36]. So, the dose in
voxel j is calculated as Di =
N∑
j
kijω
′
j
2 . Thus, the constrained optimization problem
with respect to weights is approximated by an unconstrained one in which the square
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root of the beamlet weights is used to optimize the plan rather than optimizing the
beamlet weights directly in the model. As a result, the first derivative of the revised
objective function becomes:
∂F
∂ω′j
= 4 p
T
NT
NT∑
i=1
(
Di −DT
)
kijω
′
j + 4
pOAR
NOAR
NOAR∑
i=1
(
Di −DOAR
)
kijω
′
j. (3.17)
L-BFGS-B: L-BFGS algorithm with box constraints
A major drawback of using L-BFGS for the IMPT FMO problem is its inability
of adding the non-negativity constraint. A better alternative is the L-BFGS-B algo-
rithm that is designed for solving nonlinear optimization problems with simple box
constraints on variables [76] as
min F (x)
s.t. l ≤ x ≤ u ,
. (3.18)
where l and u represent lower and upper bounds on the variables. So, this algorithm is
capable of handling the non-negativity bounds on intensity of beamlets. Theoretically,
it can solve the FMO problem to optimality and find the global optimal solution.
Molecular Dynamics
MD is a computational technique for many-body system simulation that has
been widely applied in the material sciences community. In a classical MD model,
the physical movements of particles in the system follow Newton’s Laws of Motion
[77]. Let xj be the position and vj be the velocity of a particle j. Then, force fj is
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the product of mass mj and acceleration aj of the particle:
fj = mj · aj = mj dvjdt = mj d
2xj
dt2
fj = −∇jE
, (3.19)
where t is the time of the system and E is the potential energy of the system. The
force fj is related to the acceleration and can be expressed as the gradient of the
potential energy of the particle.
Based on Newton’s Laws of Motion, the position, velocity and acceleration of
the particle can be described as functions of time t;
vj =
dx(t)j
dt
, aj =
dv(t)j
dt
=
d2x(t)j
dt2
. (3.20)
Therefore, the continuous motion configuration of the system can be calculated by
integrating Newton’s Laws of Motion. When the system is under the influence of
continuous potential energy, the positions and velocities can be approximated using
a Taylor series expansion for a small time step ∆t, ∆t > 0:
x(t+ ∆t) = x(t) + v(t)∆t+ 12a(t)∆t
2 + 16b(t)∆t
3 + . . . ,
v(t+ ∆t) = v(t) + a(t)∆t+ 12b(t)∆t
2 + 16c(t)∆t
3 + . . . ,
(3.21)
where a, b and c are the second, third and fourth time derivatives of the coordinates.
This Taylor expansion serves as the basis for the most common integrators used
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in MD calculations. Many classical methods for integrating equations require in-
formation from both current and previous steps to update the system. This means
the information from these steps must be stored in memory and the system cannot
self-start at the beginning [78]. To resolve this problem, [79] introduced the Velocity
Verlet method which requires information from the previous step only:
x(t+ ∆t) = x(t) + v(t)∆t+ 12a(t)∆t
2,
v(t+ ∆t) = v(t) + 12∆t[a(t) + a(t+ ∆t)].
(3.22)
Therefore, this approach is selected in our algorithm to update the MD system to
solve the IMPT FMO problem.
In IMPT, the optimization problem can be formulated as a dynamic system with
N virtual atoms [70]. Each beamlet weight (ωj is assumed to be the position (xj) of
a virtual atom j in 1-D dimension. The objective function F can be considered as
the potential energy E of the system. As a result, the dynamic equations for virtual
atom j can be expressed as
vj =
dωj
dt
, aj =
dvj
dt
= d
2ωj
dt2
, fj = mj
dvj
dt
= ∂F
dωj
. (3.23)
We followed the approach of [70], in which the mass of the virtual atom j equals the
summation of the unit dose contribution of all voxels influenced by the jth beamlet,
written asmj =
∑Nj
i=1 kij, whereNj is the total number of voxels influenced by beamlet
j. Using the velocity Verlet method, the dynamic updating equations for the IMPT
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FMO problem is written as
ωj (t+ ∆t) = ωj (t) + vj (t) ∆t+ 12mj ∆t
2fj (t)
vj (t+ ∆t) = vj (t) + 12mj ∆t [fj (t) + fj (t+ ∆t)]
. (3.24)
Hence, we calculate the updating beamlet weights by Eq. 3.24 and we can combine
Eq. 3.24 with Eq. 3.4 to calculate the trajectory of the OFVs.
In physics, temperature is used to specify the thermodynamic state of a system.
In the MD system, temperature T is related to the kinetic energy of the system and
can be calculated as
T = 13Nk
N∑
j=1
mjv
2
j , (3.25)
where k is the Boltzman constant and N is the total number of particles in the system.
The MD system will converge to an equilibrium state with the lowest free energy.
Note that free energy consists of kinetic energy and potential energy. Therefore, the
potential energy equals the free energy only when kinetic energy is zero, i.e., the
temperature of such system is zero. Thus, the objective function (potential energy) of
our FMO model is minimized when the system reaches an equilibrium state with zero
system temperature. However, in physics, the kinetic energy and potential energy of a
dynamic system follow the law of energy conservation. Although kinetic and potential
energy will interchange continuously, the total energy will remain unchanged. This
can create an issue of convergence to a specific point because the atoms can still carry
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significant speed when they reach that point. As a result, atoms may move away from
an optimal point with the lowest potential energy. In order to solve this problem, a
"friction" to the system (i.e., a damping factor to the MD system) is added to slow the
movements of atoms as they get closer to an optimal point. The following damping
function is applied in our algorithm,
vj (t) =

λvj (t) , if vj (t) fj(t) < 0
vj (t) , otherwise.
where 0 < λ < 1.
(3.26)
As we mentioned above, their speed may cause the atoms to pass the optimal point
and create an issue of convergence. On the other hand, when the virtual atoms become
trapped in local minima, a proper speed may help them continue to move and get out
of those local minimum points. Using this feature, we employ temperature scaling
to adjust the velocities to help the atoms move out from the local minimum points.
From the updating function, Eq. 3.24, we define the scaling function as
vj (t+ ∆t) =
√
Td
T0
vj (t) +
1
2mj
∆t [fj (t) + fj (t+ ∆t)], (3.27)
where T0 is the initial temperature and Td is the desired temperature.
An important physical constraint of IMPT planning is that the beamlet weight
cannot be negative. [70] suggested a barrier potential with an infinite height at ω = 0
to impose this constraint. The virtual atoms are reflected by changing the sign of
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their velocity each time they try to pass the barrier: vj (t) = −vj (t) ,whenωj (t) < 0.
The proposed MD method to optimize the IMPT FMO problem is outlined
below. The algorithm stops when either of these following conditions are met: (a) a
certain number of iterations is reached or (b) there is no change (smaller than , i.e.,
10−4 in the objective value for a certain number of consecutive iterations.
Algorithm 1: Molecular dynamics method
1 Initialization:δt := t0;v := 0;ω∗ := ω0;F ∗ := F0;
2 while Stopping criteria are not met do
3 Calculating force f and updating ω and v , Eq.3.24; calculating F ,
Eq.3.1-3.4;
4 if F < F ∗ − ε then
5 s
6 end
7 F ∗ := F ; ω∗ := ω; else if F < F ∗ then
8 F ∗ := F ; ω∗ := ω;
9 Heating the system by setting the desired temperature Td = βT0;
10 end
11 else
12 Heating the system by setting the desired temperature Td = βT0;
13 end
14 Damping the system by setting the atom j, if vj (t) fj(t) < 0;
vj (t) = λvj (t);
15 Checking the physical constraint, set vj (t) = −vj (t), when ωj (t) < 0.
16 end
17 return ω∗ as optimal solution.
In our implementation, if a new solution increases the OFV to a value larger
than ε, it replaces the old one. Otherwise, if the new solution increases the OFV but
the value remains smaller than ε, it replaces the old solution and the system is heated
by rescaling the temperature by Td = βT0, where β is the heating rate and typically
lies between 1.1 and 2. If there is no OFV improvement, we keep the old solution and
also heat the system. When the stopping criteria is satisfied, we stop the algorithm
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and return the final solution.
3.3 Numerical Experiments
All algorithms were implemented in C++ and all experiments were performed
on a 64-bit Linux workstation with 128 GB of memory and quad Intel Xeon E5649
2.53GHz processor. The stopping criteria were either: (a) 10,000 iteration limit or
(b) no change in the OFV for 10 consecutive iterations with ε = 10e− 5.
3.3.1 Patient Data
The three clinical cancer cases from The University of Texas MD Anderson
Cancer Center selected for this study was a prostate cancer, head-and-neck cancer
and a lung cancer case (Figure 3.1). The corresponding beam angles for each case
are marked by arrows F1, F2 and F3, respectively.
Figure 3.1: The three clinical cancer cases selected for the study and their corresponding
field directions. (A) Prostate cancer case, (B) head-and-neck cancer case, (C)
lung cancer case; the tumors are contoured in red.
The beam angles, number of beamlets in each beam, volumes of interest and
number of voxels of each volume for each case are listed in Table 3.1. The prostate
case involved a medium-sized tumor that required only a simple treatment plan in
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which parallel-opposed fields were used. The head-and-neck case had a small target
size but some very subtle OARs such as the optical chiasm. The lung case represents
a large sized tumor case. It contains twice as much target volume than the prostate
case and twice as large in total volume compared to the head-and-neck case. Because
of this, more beamlets were required to cover the tumor for the lung case.
Table 3.1: The intensity modulated proton therapy beam angles, number of beamlets in
each beam, VOIs and number of voxels of each VOI for the three cancer cases
Cancer Type Beam Angle Number of beamlets VOI Number of voxels
Prostate 90◦ 599 STV 4916
270◦ 605 Bladder 15189
Femoral heads 23908
Rectum 8570
Head-and-neck 75◦ 374 CTV 2603
240◦ 356 Brain 96536
300◦ 365 Brainstem 2506
Optic chiasm 110
Lung 205◦ 1539 PTV 11161
275◦ 1218 Esophagus 1435
345◦ 1042 Spinal cord 2030
Total lung 159188
Heart 18148
Abbreviations: VOI: volume of interest, STV: scanning target volume, CTV: clinical
target volume and PTV: planning target volume.
The planned doses and penalty weights for the corresponding VOIs in a dose-
based objective function for the three IMPT cases are listed in Table 3.2. The same
penalty was applied to different initial conditions in each case. Because the highest
priority was to satisfy the tumor coverage and dose uniformity requirements, the
penalty for the target was high. Meanwhile, the target dose to the OARs is set to 0
Gy, which means we wish to minimize the dose on OARs as low as possible.
The parameter values of each algorithm were assigned the same values for all
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cancer cases. The stopping criteria were either: (a) the number of iterations reached
10,000 or (b) there was no change in the OFV for 20 consecutive iterations, where
ε = 10e− 4.
Table 3.2: Dose-based objective function parameters used for optimizing the intensity
modulated proton therapy plans
Cancer Type VOI Dose (Gy) Weight
Prostate STV 78 200
Bladder 0 1
Femoral heads 0 1
Rectum 0 1
Head-and-neck CTV 74 200
Brain 0 1
Brainstem 0 1
Optic chiasm 0 1
Lung PTV 74 200
Esophagus 0 1
Spinal cord 0 1
Total lung 0 1
Heart 0 1
3.3.2 IMPT Starting Conditions
In this study, the IMPT plans of each of three cases were obtained from three
different initial conditions (Figure 3.2). These initial conditions have been described
by [68] and described briefly below:
(a) Forward wedge (FW). All beamlet weights are set the same creating a wedge-
shaped dose that has a high dose at the proximal edge and a low dose at the distal
edge (Figure 3.2A).
(b) Inverse wedge (IW). The beamlet weights are set to distal tracking creating
an inverse wedge-shaped dose that has a very low dose to the proximal edge and a
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high dose to the distal edge (Figure 3.2B).
(c) Spread-out Bragg peak (SOBP). The beamlet weights are arranged to deliver
a flat dose on the targeted area (Figure 3.2C).
Figure 3.2: The initial beamlet weights for a single intensity modulated proton therapy
field from three initial conditions: (A) Forward wedge, (B) Inverse wedge, (C)
Spread-out Bragg peak (SOBP).
3.4 Results
3.4.1 Solution Quality
Table 3.3 compares the objective function values obtained from three different
initial points for three patient cases using all algorithms discussed in this paper. In all
patient cases, the L-BFGS-B converged consistently to the same OFV regardless of
the starting points used. Furthermore, it produced lowest OFVs in all cases: 2265.1,
528.7 and 1992.6 for prostate, head-and-neck and lung cancer case, respectively. In
terms of OFV, MD was the second best with the gap from L-BFGS-B within 0.1%
while the MD method was not sensitive to the starting points. However, the OFVs
obtained by the quasi-Newton and L-BFGS varied significantly when different starting
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conditions were utilized as often mentioned in the literature. Especially, the quasi-
Newton method was most sensitive to the starting point that made big differences in
the final results. For example, the OFVs of head-and-neck plans are 574.1, 1150.4 and
644.3 when starting from solutions based on FW, IW and SOBP, respectively. Among
these three initial points, IW yielded the worst OFVs for the quasi-Newton and L-
BFGS methods. The dose-volume histograms (DVHs) of the scanning target volume
Table 3.3: Objective function value comparison using quasi-Newton, L-BFGS, L-BFGS-B
and the MD methods for three tested cases starting from forward wedge (FW),
inverse wedge (IW) and spread-out Bragg peak (SOBP).
Prostate Head-and-neck Lung
Algorithm FW IW SOBP FW IW SOBP FW IW SOBP
quasi-Newton 2371.4 2657.2 2339.5 574.1 1150.4 644.3 2251.1 2262.9 2135.4
L-BFGS 2311.7 2573.2 2301.8 532.6 596.2 581.9 2087.6 2094.7 2027.6
L-BFGS-B 2265.1 2265.1 2265.1 528.7 528.7 528.7 1992.6 1992.6 1992.6
MD 2265.5 2265.4 2265.5 529.3 529.1 529.3 1992.8 1993.0 1993.0
(STV) and femoral heads for the prostate case are shown in Figure 3.3. Notice that
DVHs of L-BFGS-B and the MD method were identical for all three starting points;
all three lines were not distinguishable. In contrast, the lines were different when
optimized using the quasi-Newton method and L-BFGS. The higher OFVs in Table
3.3 may reflect worse target coverage or OARs sparing in DVHs. In fact, the tiny
differences of objective function values between the MD method and L-BFGS-B is
clinically negligible. We have observed a similar result for the head-and-neck and
lung cancer cases (see Figure 1,2 in Appendix).
So far, we have demonstrated that the unconstrained optimization methods are
sensitive to the initial conditions and that both the L-BFGS-B and the MD method
can overcome the issue. We believe that such poor results of L-BFGS and the quasi
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Figure 3.3: The dose-volume results of the prostate case using quasi-Newton, L-BFGS, L-
BFGS-B and the MD method starting from three initial conditions: forward
wedge (FW), inverse wedge (IW) and spread-out Bragg peak (SOBP).
Newton method may be caused by the modification of the objective function to con-
vert the FMO model into an unconstrained one. From Eq. 3.11 and 3.17, the ωj or
ω′j is a multiplier of updating function or gradient of the objective function. When ωj
or ω′j is equal to 0, it will not be updated during the optimization process. This may
happen in the initial setting or during the optimization loop. This shows the inappro-
priateness of solving the FMO problem as an unconstrained optimization problem.
For the MD method, changing the velocity direction of virtual atoms can handle the
bounds on variables, which resulted in achieving the near global optimal.
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3.4.2 Computational Performance
Computational performance of the three algorithms is discussed in this section.
Table 3.4 shows the CPU times in minutes of the four algorithms on three different
sizes of cancer patient cases. For each pair of algorithm and a cancer case, CPU time
is recorded for each starting point specified. Overall, the quasi-Newton method was
faster than all the rest of methods, but the compute time was clearly influenced by
the starting points. Although L-BFGS-B was the best performer in solution quality,
it took considerably longer time to converge when compared with the rest of the three
algorithms. The CPU times of the MD method were comparable to those of the two
unconstrained algorithms and it was significantly faster than L-BFGS-B in all cases
tested. For prostate, head-and-neck and lung case, the average CPU times of MD
method were 80%, 76% and 58% percent faster than the results of L-BFGS-B for each
of the three starting points, respectively. For prostate and head-and-neck cases, the
MD method was faster than L-BFGS.
Table 3.4: Time comparison using quasi-Newton, L-BFGS, L-BFGS-B and the MD meth-
ods for three tested cases starting from forward wedge (FW), inverse wedge
(IW) and spread-out Bragg peak (SOBP).
Prostate (min) Head-and-neck (min) Lung (min)
Algorithm FW IW SOBP FW IW SOBP FW IW SOBP
quasi-Newton 16.2 23.5 10.7 27.4 14.8 18.9 121.7 103.1 92.3
L-BFGS 25.5 33.6 32.4 39.5 27.7 20.8 112.4 145.6 132.3
L-BFGS-B 112.6 106.4 103.8 99.6 78.8 82.0 315.3 362.1 354.6
MD 21.5 20.6 19.9 22.1 18.5 21.6 156.6 135.1 140.3
We further analyzed the convergence of the algorithms. Figure 3.4 shows the
plots of OFVs as a function of CPU run time for the prostate cancer case. Each
sub-figure shows convergence of the four algorithms for each starting point. We
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observed that the MD method quickly converged to near optimal within five minutes
of computation in all cases. Running MD beyond five minutes did not show much
improvement in OFV. Similarly, L-BFGS-B reached a ’flat region’ after 30 minutes
for all three starting points. Influence of the starting points for convergence of an
algorithm seems to be clear from these figures. Especially, the inverse wedge (IW)
starting point seems to be much worse than FW or SOBP. The reason is that the
proximal beamlets weights are more likely to be set to zero for the inverse wedge
shape of initial dose. Similar results were also observed in the head-and-neck and
lung cancer cases (see Figure 3,4 in Appendix).
Figure 3.4: The objective function value as a function of time for the optimization pro-
cesses for the prostate case starting from FW, IW and SOBP using quasi-
Newton, L-BFGS, L-BFGS-B and the MD method.
Overall, the MD method stands out as the best approach when minimizing both
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the objective function and the CPU time are important in obtaining a radiation
treatment plan.
3.5 Conclusion
We have demonstrated that the commonly used QP model for IMPT FMO prob-
lem has a global optimal solution, which is contradictory to over a decade-old claim
by researchers in the medical physics community that the model has many local op-
tima. The literature also claims that popular gradient based solution algorithms for
solving the QP model are sensitive to the starting condition. We found that there
might be two compelling reasons for such shortcomings claimed by these researchers;
unconstrained QP models are frequently used for solving the problem that requires
non-negativity constraints on variables, and solution algorithms are incorrectly mod-
ified to address the non-negativity constraints, which results in premature termina-
tion. We then provided two remedies to fix these issues and achieve global optimal
solutions: the use of a constrained QP model and a fast solution algorithm to solve
the constrained optimization model. Specifically, the MD method was developed to
optimize the IMPT treatment plans. The performance of the MD method was com-
pared against a well cited quasi-Newton method and L-BFGS as well as L-BFGS-B
using three clinical cancer cases of different size. For the comparison purpose, three
suggested initial conditions were used to test each of these methods. By the compu-
tational results, we have confirmed that both the quasi-Newton method and L-BFGS
were sensitive to the initial conditions. But more importantly, we have shown that
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the MD method consistently produced solutions that were the same or within a neg-
ligible margin of error to the global optimal solutions found by L-BFGS-B regardless
of the initial conditions used. Although L-BFGS-B can guarantee global optimal, it
took considerably longer time to converge. The MD method converged to a ’flat area’
of objective function value in five minutes, while L-BFGS-B took 30 minutes to reach
a similar point.
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Chapter 4
Robust Optimization for Intensity
Modulated Proton Therapy Plans with
Multi-Isocenter Large Fields
Conventional proton therapy for the patients with a large size tumor usually
requires multiple fields combining together to create a multi-isocenter large field to
cover the whole target. It is a complex treatment planning procedures, and plans can
be subject to dose inhomogeneity caused by field mismatches in junction areas. In this
chapter, we propose and validate a robust optimization approach for intensity mod-
ulated proton therapy treatment plans with multi-isocenter large fields to overcome
these limitations and potentially improve treatment planning efficiency and patient
safety. The field alignment uncertainties are incorporated into treatment planning
optimization process. The results demonstrated that the robust optimized IMPT
treatment plan creates a low-gradient field dose in the junction regions to mitigate
the impact caused by misalignment errors and is more efficient than the conventional
planning technique.
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4.1 Introduction
Proton therapy is being used for an increasing range of disease sites as a result
of the development of patient-specific planning and delivery techniques that improve
the therapeutic ratio by taking advantage of finite proton ranges in patients [80, 81,
82, 83, 84, 85]. For large and irregular-shape tumors, such as craniospinal irradiation
(CSI) [83, 84, 86] and mesothelioma irradiation [82], techniques are being developed
for patient treatment. In those cases, the size of the target volume normally exceeds
the mechanical limitations of the treatment field size, and multiple fields with different
isocenters are required to be matched together to cover the target [87, 88]. Normally,
the field dose in the junction area has a steep gradient, which makes the treatment
plan sensitive to misalignment errors, and even small uncertainties can significantly
affect dose uniformity. Traditionally, preventing the risk of dose deviation in junction
regions usually requires a manual shift of the field junctions, which can be technically
challenging.
In conjunction with the development of applying intensity modulated proton
therapy (IMPT) to more disease sites, there is a major progress in the robust optimiza-
tion techniques [44, 89, 42, 37]. Robust optimization methods have been developed
for mitigating the effects of proton range, setup and anatomical motion uncertainties
on dose delivered to a patient. However, none of the robust optimization methods
reported in literature are dealing with the junction mismatch which is special for the
large and irregular targets.
In this chapter, we introduce a general robust optimization approach for IMPT
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plans with multi-isocenter large fields. This approach incorporates field misalignment
uncertainties during the optimization process and generates a low-gradient field dose
in junction regions.
4.2 Material and Methods
We selected one CSI case and one mesothelioma case to demonstrate the use
of the proposed approach. Both patients underwent the simulation in the supine
position. Images were obtained from patients in the treatment position with a multi-
slice CT scanner at a 2.5-mm slice thickness. Target structures and organs at risk
were outlined by experienced dosimetrists or radiation oncologists. The clinical target
volume (CTV) in the CSI patient comprised the brain and spinal canal and was
extended caudally to just beyond the thecal sac. In the mesothelioma patient, the
gross tumor volume (GTV) encompassed gross disease on the postsurgical positron
emission CT scan, the CTV was contoured by radiation oncologist, and the planning
target volume (PTV) was consist with a 0.5-cm margin expansion around the GTV
plus a 6-mm internal margin and a 1-cm external margin expansion on CTV.
For the CSI patient, a radiobiological equivalent dose of 36 Gy in 1.8-Gy fractions
was prescribed for CTV. For the mesothelioma patient, the prescription dose was 45
Gy in 1.8-Gy fractions to PTV. For contouring, spot arrangement and dose we used
the Eclipse version 13.0 system (Varian Medical Systems, Palo Alto, CA). The robust
optimization was performed using an in-house proton treatment planning system [44].
All plans were normalized to 95% of target volume (i.e., CTV for CSI case, PTV for
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mesothelioma case) received 100% prescribed dose. The homogeneity index (HI =
D5/D95) was used to evaluate the target dose uniformity. The beam has a spot size
with a diameter of approximately 1.6-2.2 cm (full width half maximum).
4.2.1 Field Setup and Spot Arrangement
Figure 4.1A-C show representative axial, sagittal and coronal views with marked
field projections for the CSI patient. Two brain fields with the same isocenter are
typically angled 15◦ posteriorly from the horizontal plane to reduce the dose to the
lens (Figure 4.1A). For each field, the corresponding CTV included the brain contour
and a portion of the upper spine contour that extended approximately 1 to 2 cm
superior to the shoulders (Figure 4.1D). The spinal fields were equally spaced along
the spine axis, and the isocenters were designed to minimize the total number of
spinal fields and maximize the field overlap region for junctions (Figure 4.1B, C).
The target covered by the spinal field immediately inferior to the brain fields may
include the upper spine as well as portions of the brain target (Figure 4.1E). The
maximum field size of our system is 30 cm × 30 cm; to maximize junction size, we
applied a 45◦ couch rotation for spinal fields (Figure 4.1C, E and F). Figure 4.1G
and H show representative axial and sagittal views with marked field projections for
the mesothelioma patient. The PTV was covered by four fields (Figure 4.1G): two
upper fields with one isocenter matched with two lower fields with another isocenter
(Figure 4.1H). The corresponding targets for the upper and lower fields are shown in
Figure 4.1I and J. For both patients, the spot arrangement volume of each field was
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expanded by 8 mm uniformly in all directions from the corresponding target contour.
Figure 4.1: Field arrangement for the craniospinal irradiation patient (A-F) and mesothe-
lioma irradiation patient (G-J).
56
4.2.2 Robust Optimization and Uncertainty Setup
In our in-house proton treatment planning system, the worst-case dose algorithm
is adopted for robust optimization. In this algorithm, the dose distributions from dif-
ferent scenarios, including the nominal dose (i.e., without uncertainties) and different
uncertainty setups, are computed. The worst-case dose distribution is represented by
the maximum (for overdosage) or minimum (for underdosage) dose from all computed
dose distributions in each voxel corresponding to specific structures. The formulation
can be described as
min FRobust =
∑
i∈T
ωT,min(Di,min −Dp,T )2
+ ∑
i∈T
ωT,max(Di,max −Dp,T )2
+ ∑
i∈OAR
ωOAR(Di,max −Dp,OAR)2+
, (4.1)
where Di is the worst-case (minimum or maximum) dose on voxel i, Dp is the pre-
scription dose of target or OARs, ω is the penalty weight of the specific structure,
(δ)+ is defined as (δ)+ = max (δ, 0). Different dose distributions need to be computed
and the worst-case dose are penalized during the optimization iterations.
We designed two uncertainty scenarios for robust optimization to simulate mis-
alignment errors that may occur at all field junctions. In these scenarios, field isocen-
ters shift ±3 mm in the superior-inferior direction alternately. For example, for CSI
patient, two brain fields are shifted by -3 mm, and the first and second spinal fields
are shifted by +3 and -3 mm in scenario I, respectively. In scenario II, the fields are
shifted by 3 mm in the opposite direction with respect to scenario I.
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4.2.3 Dosimetric Evaluation
Dose uniformity in targets was evaluated with the heterogeneity index [HI =
D5/D95] and inhomogeneity coefficient [IC = (D5 -D95)/Dmean]. Selected dose indices
for the targets and OARs were also evaluated. All plans were normalized to 95%
of the CTV receiving 100% of the prescription dose. Paired t tests were used to
assess potential differences (Excel, Microsoft Corp.). A dose-volume histogram (DVH)
"band" was used to illustrate the robustness of the IMPT plans to uncertainties (a
narrower band indicates greater robustness).
4.2.4 Plan Robustness Evaluation
Robust optimized and conventional, nonrobust IMPT plans were generated for
both patients. Alternating isocenter shifts of 3 mm per field (6-mm total error) were
performed to simulate the longitudinal mismatching error for robustness analysis. The
dose profiles in the junction regions were used to demonstrate the deviation caused
by misalignment uncertainty. For the CSI patient, robust IMPT plans with different
junction sizes (8, 12, 16 and 26 cm) were generated to illustrate the relationship
between junction size and dose deviation, and the robustness of a robust optimized
IMPT plan with a large junction size was compared with that of a robust optimized
treatment plan with a small junction and conventional junction shifting.
4.3 Results
First, we evaluated the robustness of the dose distribution in field junctions
for the robust and conventional IMPT plans. The Figure 4.2 demonstrate the dose
58
color wash and the corresponding dose profiles from the robust and non-robust plans
for two tested case. The dose color wash and dashed lines represent the dosimetric
deviations resulting from a 3-mm alternating misalignment error. As shown in Figure
4.2A, the field dose in the junction region has a low smooth gradient in the robust
IMPT plan but is irregular (non-smooth) in the conventional IMPT plan (Figure
4.2B).The hot and cold doses were evenly distributed in the junction region in the
robust plan, and the deviation for the simulated error was around 5% (Figure 4.2A),
which is significantly smaller than the 20% deviation in the conventional plan (Figure
4.2B). Similar results were observed for the mesothelioma patient (Figure 4.2C, D).
Figure 4.2: Dose color wash and corresponding dose profiles of the robust and conven-
tional IMPT plans for the craniospinal irradiation patient (A, B) and the
mesothelioma patient (C, D).
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Figure 4.3 shows the dose profiles in robust IMPT plans for the CSI case with
different junction sizes (8, 12, 16 and 26 cm) and a 3-mm misalignment error. And
the uncertainty yield 9.9%, 5.4%, 4.5% and 2.6% dose deviation in the junction region
for the IMPT plans with 8, 12, 16 and 26 cm junction size respectively. For a given
uncertainty level, the dose deviation decreased as junction size increased. This result
is also consistent with the results reported in previous study [83, 84]. The relationship
between dose deviation, uncertainty and junction size can be rough simplified as
Dose deviation(%) = UncertaintyJunction Size × 100% . (4.2)
Figure 4.3: Dose profiles in junctions for the CSI IMPT plans with junction sizes of 8, 12,
16 and 26 cm and a longitudinal misalignment error of 3 mm per field (total,
6 mm).
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Figure 4.4 demonstrates two strategies to increase the robustness of the mis-
alignment errors: a robust IMPT plan with an 18-cm dose junction and a robust
IMPT plan with a 7-cm dose junction and junction shifting. The second plan in-
cludes three subplans, each delivering 1/3 of the total dose. The total lateral dose
profiles for the two plans are quite similar. Each subplan in the second plan has large
dose deviations, but shifting the junction helps to spread the uncertainty. Thus, in
general,the dose deviations of the two plans are similar. This result suggests that if
the overlapping region is sufficiently enlarged, the shifting of junctions will not be
necessary for the robust IMPT plan.
Figure 4.4: Robustness comparison between a robust IMPT plan with a large dose junc-
tion (18 cm) and a robust IMPT plan with a small dose junction (7 cm) and
junction shifting for the CSI patient.
The dose volume histograms (DVHs) of robust and non-robust IMPT plans
were illustrated in Figure 4.5. The tradeoff between target uniformity and robustness
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between robust and non-robust IMPT plans was within 1.5% for two patient cases.
For CSI patient, the HI of spinal cord, brain and cribriform plan were 1.041, 1.051
and 1.030 in robust IMPT plan compare to 1.036, 1.045 and 1.025 in non-robust
IMPT plan. And the mean doses of left lens and right lens were increased from 8.9
Gy and 8.7 Gy to 10.3 Gy to 10.1 Gy from non-robust plan to robust plan. For the
mesothelioma case, robust IMPT plan achieved similar plan quality of non-robust
plan in nominal scenario. for two patient cases. For CSI patient, the HI of spinal
cord, brain and cribriform plan were 1.041, 1.051 and 1.030 in robust IMPT plan
compare to 1.036, 1.045 and 1.025 in non-robust IMPT plan. And the mean doses of
left lens and right lens were increased from 8.9 Gy and 8.7 Gy to 10.3 Gy to 10.1 Gy
from non-robust plan to robust plan. For the mesothelioma case, robust IMPT plan
achieved similar plan quality of non-robust plan in nominal scenario.
Figure 4.5: Dose volume histograms of robust and non-robust IMPT plans for craniospinal
irradiation patient (A) and mesothelioma patient (B). Solid lines: robust
IMPT plan; Dashed lines: non-robust IMPT plan.
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4.4 Discussion
Robust optimization is aimed at reducing uncertainty in IMPT. Whereas pre-
vious studies only investigated setup errors in single-isocenter treatment plans [44],
the current study provides, to our knowledge, the first demonstration of efficient inte-
gration of intrafractional setup errors for multi-isocenter fields into a general robust
planning algorithm. Such robust optimization is especially important for treatment
planning for large, complex and irregular-shape targets.
Many strategies have been proposed to handle field misalignment errors dur-
ing treatment. For CSI treatment planning, a volumetric gradient dose optimiza-
tion (GDO) methodology [90] was recently introduced for IMPT technology [83, 84].
The GDO method, which was initially introduced for volume modulated arc therapy
(VMAT) planning [90], is a two-step manual planning approach. In this method,
gradient volumes are generated in the overlap regions as four equally spaced sections.
The first step is to optimize the first volume field so that the four gradient volumes
receive 80%, 60%, 40% and 20% of the prescribed volume. The second step is to
optimize the second field separately so that the four gradient volumes receive 20%,
40%, 60% and 80% of the prescribed volume. This method, which produces a tapered
dose distribution in the junction regions, has several limitations. (i) In both VMAT
and IMPT planning, the GDO method increases the optimization time significantly,
since the manual GDO requires delineation of structures for optimizing the dose in
the junction and running extra optimizations. So, an automatic process is desired.
(ii) In GDO method, the assigned field dose in gradient volumes was not continuous,
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so it is hard to produce a more general tapered dose distribution for large junction
sizes. (iii) The GDO method applies single field optimization. This process cannot
be used for mesothelioma cases since it often requires at least two fields for each
isocenter. A non-optimal GDO solution for a large overlap region has been described
for a VMAT optimization [90].
An important finding of the current study is that dose gradients that are low
and tapered in field junctions can be achieved through a robust optimization that is
much more general and simple than manual single-field optimization [83, 84]. Our
approach overcomes the limitations of the GDO method in that it (i) is automated,
(ii) can be used for any junction size and (iii) use multi-field optimization and can be
used for large and complex targets. In addition, as the use of scanning beam proton
therapy is increasing, the robust optimization planning method is being implemented
in commercially available treatment planning systems, such as Eclipse V13.7 system
(Varian Medical Systems, Palo Alto, CA). So, our general robust optimization method
for multi-isocenter large field treatment plan can be easily applied in other proton
therapy center. Our work is the first time to report the utilization of this automatic
process for two distinct disease sites.
As shown above, robust IMPT greatly improves the efficiency of treatment over
conventional IMPT. For the CSI treatment, one of the important results is that
junction shifting was not necessary. For the mesothelioma treatment, the second
isocenter was setup simply by shifting the couch during the treatment, since the plan
is robust to intrafractional junction shifting. Currently, our center uses the robust
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optimization planning approach for complex-target treatments and can perform CSI
or mesothelioma IMPT in 45-min sessions.
Figure 4.6: Dose volume histograms of robust IMPT plan with fixed brain fields uncer-
tainty setup and non-robust IMPT plan for craniospinal irradiation patient.
Solid lines: robust IMPT plan; Dashed lines: non-robust IMPT plan.
Although the robust optimization tools have been well developed, planners are
still lack of experience in clinical application. The setup of uncertainty scenarios is
crucial for the use of robust optimization in clinical practice. The inclusion of too
many scenarios will increase the computation burden and thereby prevent optimiza-
tion in an acceptable time frame, whereas the inclusion of too few scenarios may not
guarantee robustness. How to balance the plan robustness and quality in nominal
scenarios also need more experience. For example, in CSI case to increase the dose
conformality in brain target and keep taped dose in junction. The uncertainty sce-
narios can change to two brain fields are kept still and the first and second spinal
fields are shifted by Âś3 mm. The DVHs of this uncertainty setting are demonstrated
in Figure 4.6. It shows that in brain target robust IMPT plan achieved the same plan
quality of non-robust IMPT plan in nominal case. The selective robust optimization
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strategies [91] also can apply to increase the dose uniformity in nominal case. In
this study, we only discussed uncertainty scenarios to generate a robust field junc-
tion. The conventional interfractional patient setup uncertainties and system range
uncertainties can also be integrated into treatment plan optimization.
4.5 Conclusion
A robust optimization approach for multi-isocenter large field IMPT has been
developed. Several types of uncertainty during the CSI can be incorporated into
optimization process. As a result, this approach can easily generate low gradient
doses in field junctions and minimize dose deviations introduced by uncertainties.
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Chapter 5
Two-stage Method for IMPT Beam Angle
Optimization Incorporating Internal
Organ Motion
Intensity modulated proton therapy (IMPT) is highly sensitive to uncertainties
such as internal organ motion. Considering the motion uncertainty in beam angle
selection is a complex optimization problem in IMPT treatment planning. To solve
this problem efficiently, we developed a two-stage robust beam angle optimization
(TSBAO) method for IMPT treatment planning. The goal of the first stage is to
determine an appropriate initial number of beam angle clusters and assign angles to
each of these clusters based on prior knowledge. A p-median algorithm is developed
for beam angle clustering using two different measures: score function and similarity
measure. The merit of an individual beam angle is associated with a score function
incorporating the internal organ motion uncertainty. Another measure is to evaluate
the similarity between two angles. For the second stage, a bi-level local neighbor-
hood search (bi-LNS) algorithm is used to determine the final beam angle set for the
treatment. Support vector machine (SVM) is used in bi-LNS to reduce the search
space. Our methods were tested on four thoracic clinical cancer cases. TSBAO was
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tested against several well-known heuristic methods found in literature, including a
standalone LNS, simulated annealing (SA), genetic algorithms (GA), hybrid SA-LNS
and hybrid GA-LNS. Results show that TSBAO consistently outperformed other
methods in both objective value and CPU time. Furthermore, all TSBAO optimized
treatment plans achieved more uniform and robust target dose distributions than the
competitors did.
5.1 Introduction
As proton therapy has improved the therapeutic ratio by taking advantage of
finite proton ranges in patients, it has been adopted for treating more and more
disease sites by developing patient specific planning and delivery techniques [80, 81,
82, 83]. Intensity modulated proton therapy (IMPT) is an advanced proton delivery
technique that uses modulated proton beams to produce three dimensional conformal
dose distribution to cover the target [92, 93]. Similar to conventional photon based
radiation therapy, the treatment planning procedure of IMPT also consists of two
sequential optimization problems: beam angle optimization (BAO) which is to find
an optimal beam angle set and fluence map optimization (FMO) which is to determine
the optimal weights or intensities of beamlets. Often, the FMO problem is embedded
into the beam angle selection problem.
The purpose of BAO of IMPT treatment planning is to select the most suitable
beam angles to achieve uniform target dose coverage with a minimum radiation ex-
posure to organs-at-risk (OAR). The BAO problem is a combinatorial optimization
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problem which is known to be NP-hard [94]. In current clinical practice, treatment
beam angles are manually selected by planners based on their clinical experience
and/or a trial-and-error process.
Many researchers have reported methods to automatically select optimal beam
angles in the literature. The majority of the algorithms combine BAO and FMO
together to formulate the BAO problem as a mixed integer programming (MIP) prob-
lem. Sonderman D and Abrahamson PG [45] first proposed the MIP model for beam
angle selection for the conventional conformal radiation therapy. Stain et al. [46]
introduced an MIP model to solve the BAO for IMRT (intensity modulated radia-
tion therapy), which incorporated the FMO in IMRT to guide the beam selection.
In order to solve this MIP problem more efficiently, different algorithms have been
proposed. Generic algorithm (GA), simulated annealing (SA) and particle swarm
algorithm were designed to find the global optimal solution for BAO [49, 52, 53, 51].
Aleman et al. [56] introduced a neighborhood search algorithm for BAO to find a
local optimal solution in a fast manner. Lim GJ and Cao W [38] proposed a two-
phase method, which used a Branch and Prune (B&P) algorithm combined with a
local neighborhood search method focusing on reducing CPU time. Based on the
advantages of different algorithms, Lim GJ, Kardar L and Cao W [58] introduced a
hybrid framework to improve the efficiency of BAO in IMRT. Although these algo-
rithms can solve the beam angle selection problem, they still require a large number
of iterations and the performance may be sensitive to the choice of initial solution
and the algorithmic parameters [58].
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To avoid excessive time for solving the BAO problem, prior knowledge was em-
ployed to guide the beam angle selection and to reduce the search space. Pugachev
A and Xing L. [59] introduced scalar scoring functions to rank candidate beam di-
rections by using beam’s-eye-view (BEV) projections technique. Schreibmann E and
Xing L [64] ranked the beam orientation based on dose-volume information for IMRT
beam selection. Lim GJ, Holder A and Reese J [66] facilitated a Euclidean metric in
a space of characteristic vectors for scoring the candidate beam directions. Based on
these beam angle information, different algorithms have been introduced to solve the
BAO problem [95, 73, 96]. These algorithms typically select or eliminate beam angles
iteratively according to individual beam information. However, they are shown to be
sensitive to initial parameter values [58].
In general, proton-based treatment plans are more sensitive to treatment uncer-
tainties than the photon-based treatment plans such as IMRT. In IMPT treatment
planning, proton beams deliver majority amount of dose at Bragg peaks that spans a
small region. In consequence, even a small uncertainty during treatment can result in
displacement of Bragg peaks to lead a significant dose deviation between actual dose
and planning dose. It is especially for thoracic cancer patients that the respiratory
motion during the treatment can induce severe target dose degradation [97, 37, 89].
In order to reduce the impact of uncertainties, various robust optimization models
of FMO have been reported to generate a steady dose distribution under different
uncertainty settings [37, 20, 44]. However, all these methods require extra calculation
for uncertainty scenarios that can severely increase the computational efforts [98].
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Solving the optimization models can be even harder if a robust FMO problem is in-
tegrated into beam angle optimization in IMPT. So, a prior knowledge-guided BAO
algorithm incorporating uncertainty for IMPT treatment planning is desired because
it can considerably reduce the computational time.
Therefore, we propose a two-stage beam angle optimization framework for solv-
ing the BAO problem in IMPT planning considering (1) uncertainty of internal organ
motion and (2) prior knowledge of beam information. Within this framework, a p-
median algorithm is used to cluster the candidate beam angles for simplify beam
angle search. A score function is introduced as prior knowledge to evaluate the merit
of a beam angle under uncertain internal organ motion to help expedite the beam
angle selection process. To overcome the drawbacks of iteratively selecting beam an-
gles, a bi-level local neighborhood search (bi-LNS) algorithm is developed. Bi-LNS
incorporates a support vector machine (SVM) for candidate beam angle classification
in order to reduce the search space.
The remainder of this paper is organized as follows. Section 5.2 describes the
optimization models, solution methods, and the experiments setup. The results are
shown in Section 5.3. Section 5.4 discusses the insights of results and conclusions are
presented in Section 5.5.
5.2 Material and Methods
This section describes the proposed two-stage beam angle optimization method
to select an optimal beam angle set for IMPT treatment. A given angle set is evaluated
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by an imbedded 4D robust fluence map optimization model that determines optimal
beamlet weights, while incorporating internal motion uncertainty. It is assumed that
the number of total candidate beams (N = |A|) is finite and the number of final beam
angles for the treatment (k) is given as an input.
5.2.1 4D Robust Fluence Map Optimization Model
For thoracic cancer, the tumor inside the chest usually moves significantly due
to respiratory motion during the radiation treatment. The magnitude of internal
organ motion can be measured by four-dimensional computed tomography (4DCT)
data. The whole 4DCT includes 10 CT datasets representing temporal phases of a
respiratory cycle. Phase CT0 is the maximum inhale phase, while Phase CT50 is
the maximum exhale phase. All other phases are between these two extremes. The
average CT (CTave) is calculated using the mean CT numbers of the 10 temporal CT
phases of 4DCT at each pixel location. In conventional IMPT, only CTave is used
for treatment planning, that is not sufficient to guarantee a robust dose distribution
in target area when accounting internal organ motion [99]. Hence, we optimize the
beamlet weights based on more 4DCT data (i.e., including CTave and two extreme
conditions CT0 and CT50) to yield a robust dose distribution under the internal organ
motion situation.
The robust FMO model is formulated based on a worst case dose model [44],
which was introduced by Lomax et al. [97]. In order to calculate the worst-case dose
distribution, different dose scenarios are calculated independently on different CT
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phases (i.e., CTave, CT0 and CT50). In the target volume, the worst-case dose of this
voxel is set as the minimum of all dose scenarios if the actual dose is lower than the
prescription dose; if the actual dose is higher than the prescription, the worst-case
dose is the maximum of all dose scenarios. If the voxel is located in the surrounding
OARs and normal tissues, the dose of this voxel is set as the maximum of all dose
scenarios.
For illustration, suppose that there are R dose scenarios based on different CT
phases. The dose deposit on voxel i under scenario r is calculated as
Dri =
∑
a∈A¯
∑
j∈Ba
dri,a,jωa,j, ∀i ∈ VΩ, Ω ∈ T ∪O, r ∈ {R} , (5.1)
where ωa,j is weight or intensity of beamlet j in beam angle a, a ∈ A¯, j ∈ Ba and it
is the primary decision variable of the FMO model. Set A¯ contains the beam angles
used in a treatment plan; Ba is the beamlet set for beam angle a; dri,a,j represents the
dose contribution to voxel i from beam angle a and beamlet j; T and O are set of
target structure and OAR, respectively. The voxel set within structure Ω is denote
as VΩ.
So, the worst-case dose can be calculated as
Di∈VΩ =

max
r
Dri , D
r
i ≥ PΩ
min
r
Dri , D
r
i < PΩ
Ω ∈ T, r ∈ R, (5.2)
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Di∈VΩ = maxr D
r
i , D
r
i ≥ PΩ, Ω ∈ O, r ∈ R, (5.3)
where, PΩ denotes the control parameter for the structure Ω, i.e., dose prescription
of the target and dose limitation of OARs. Thus, using this dose formulae (1-3), the
robust FMO model can be expressed as
min F (D)
ω
= ∑
Ω∈T
(
1
|VΩ|
( ∑
i∈VΩ
λ+Ω(maxr D
r
i − PΩ)2+ +
∑
i∈VΩ
λ−Ω(PΩ −minr Dri )2+
))
+ ∑
Ω∈O
(
1
|VΩ|
( ∑
i∈VΩ
λ+Ω(maxr D
r
i − PΩ)2+
))
,
s.t. ωaj ≥ 0,
(5.4)
where (·)+ represents max{·, 0}. Parameters λ+Ω and λ−Ω are the penalty coefficients
of structure Ω on hot and cold spot, respectively; and |VΩ| is the number of voxels in
structure Ω. The first and second terms penalize the maximum violations between
different scenarios on the target for both hot and cold spots to achieve a uniform dose
distribution. The third term penalizes overdose on OARs. The penalty coefficient of
each objective function can be adjusted according to the clinical requirements.
5.2.2 Beam Angle Clustering
The first stage of the TSBAO method is to cluster the candidate beam angles
according to the clinical merits of each angle. Hence, similar beam angles are grouped
into the same cluster, and an angle is selected as a representative beam angle for
each cluster, which is called a centroid. The p-median method is commonly used
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for solving the clustering problem [100]. The beam angle clustering problem using
p-median method can be formulated as
xa =

1 if beam angle a is selected for treatment plan
0 otherwise,
yaa′ =

1 if beam angle a′ is allocated with a
0 otherwise,
(5.5)
min WM =
∑
a∈A
∑
a′∈A
S (a)θ(a, a′)yaa′
s.t. ∑
a∈A
yaa′ = 1,
∑
a∈A
xa = M,
xa ≥ yaa′ ,
xa ∈ {0, 1}, yaa′ ∈ {0, 1},
a, a′ ∈ {A} ,
(5.6)
where, A denotes the total candidate beam angle set; M is the total number of beam
angle clusters; S (a) is beam angle score function to describe the potential of beam
angle a will be selected in treatment plan. Likewise, θ(aa, aa′) is a function that
measures the similarity between beam angles a and a′. The details of these two
functions are described in the following sections.
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5.2.2.1 Beam Angle Scoring
To measure the potential of a beam angle to be selected in the final treatment
plan, we introduce a revised beam angle score function to evaluate each candidate
beam angle. This score function is calculated based on dose contribution information
from each beam angle. It consists of OAR sparing score and target robustness score.
Both of these scores include multiple sub-scores which measure the ratio of dosimetric
deposition in a structure over the total dose contribution from the beam angle under
uncertainty, and they are expressed as
S(a)rΩ = 1|VΩ|

∑
i∈VΩ
∑
j∈Ba
dri,j∑
i∈VT∪VO
∑
j∈Ba
dri,j
 a ∈ A, Ω ∈ {T,O}, r ∈ {R} , (5.7)
where, ∑
i∈VT∪VO
∑
j∈Ba
dri,j is the total dose contribution from angle a in scenario r , and∑
i∈VΩ
∑
j∈Ba
dri,j is the dose deposition in structure Ω from angle a in scenario r. A smaller
value of the ratio is preferred.
For the OAR sparing, the score is defined as a linear combination of sub-scores
of OAR structures in the nominal scenario (CTave)
S(a)OAR =
∑
Ω∈O
λΩS(a)nominalΩ . (5.8)
Coefficient λΩ is an avoidance factor for different structures and it is consistent with
the penalty coefficient in FMO model(Eq. 5.4).
For the target robustness score, the function calculates the maximum different
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between sub-scores of target structures in different dose scenarios
S(a)Target =
∑
Ω∈T
λΩ ·max
∣∣∣S(a)rΩ − S(a)r′Ω∣∣∣ r, r′ ∈ R. (5.9)
Therefore, the total beam angle score is the summation of the OAR sparing score
and the target robustness score,
S(a) = S(a)OAR + S(a)Target. (5.10)
In this approach, a beam angle with a lower score is preferred for the treatment plan.
5.2.2.2 Similarity Measure of Beam Angles
The similarity between two beam angles is calculated by measuring the Eu-
clidean distance between sub-scores of two beam angles in the nominal scenario. The
similarity function is defined as
θ(a, a′) =
√ ∑
Ω∈{T,O}
(S(a)nominalΩ − S(a′)nominalΩ )2 a, a′ ∈ A. (5.11)
5.2.2.3 Estimating the Number of Beam Angle Clusters
In the p-median problem, the number of clusters M is an input parameter to
the optimization model and the value of M has a direct impact on the objective
function value (W ∗M). Therefore, choosing a right value of M is critical for the p-
median problem. Different methods for selecting an appropriate number of clusters
have been reported in the literature [101, 102, 103].
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Figure 5.1 depicts the normalized objective value (W ∗M/W ∗1 ) as a function of M .
Note that, the value of W ∗M/W ∗1 decreases as M increases and the decreasing rate
gradually slowed down. According to Lim et al. [103], The slope is defined as
ΨM = 180pi arctan
(
W ∗M−1−W ∗M
W ∗1
N
)
, 1 < M < N, (5.12)
where, N = |A| is the total number of candidate beam angles. The slope (ΨM) as
a function of M is demonstrated in Figure 5.1 (the line with dots). The transition
point of a slope can be defined as the point where ΨM changes from the value ≥ 45◦
to the value < 45◦. For example, the number of clusters is 6 for the data showed
in Figure 5.1. In our BAO problem, because we need to find k beam angles for the
treatment plan, so the number of clusters is set to be at least k (i.e., M ≥ k).
Figure 5.1: Normalized p-median objective function value (blue bar) and slope (orange
dotted line) as a function of cluster number M.
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5.2.3 Bi-level Local Neighborhood Search (Bi-LNS) for BAO
In this section, the goal is to search the final k beam angles for the IMPT
treatment planning based on the clustering results from Section 5.2.2.
5.2.3.1 Local Neighborhood Search
The local neighborhood search (LNS) algorithm has been widely used to solve
the beam angle optimization problem in radiation treatment planning [58, 98]. In
general, LNS finds a local optimal solution fast subject to the neighborhood definition
for a given starting feasible solution. The general procedure of LNS is described in
Algorithm 2. Let A¯ be a starting solution, where A¯ ⊂ A. We solve the FMO and
obtain the objective value z(A¯). Then we search the neighborhood of A¯(N(A¯)) and
solve the FMO for each neighbor. If a new solution (A¯′) yields a better objective
value, such that z(A¯′) < z(A¯), both the solution and the objective value are updated
accordingly then repeat the search process. Otherwise the algorithm stops, and the
current solution A¯ is the final solution.
Algorithm 2: Local neighborhood search
1 Initialization:Generate A¯0, solve FMO and find z(A¯0), i = 0, A¯∗i = A¯0,
z∗i = z(A¯0);
2 do
3 i = i+ 1;
4 Generate N(A¯∗i−1) the neighborhood of A¯∗i−1;
5 Enumerate all beam angle sets in N(A¯∗i−1), and save the lowest objective
value as z∗i , A¯∗i ← arg min{z∗i };
6 while Stopping criteria are not met;
7 Stop. (z∗i−1, A¯∗i−1) is the final local optimal solution.
The neighborhood of beam angle set A¯ is achieved by exchanging one or more
79
beams between A¯ and the rest of candidate beam angles (A\A¯). The neighborhood
size can increase exponentially if two or more beam changes are allowed to form a
new neighborhood. In order avoid this exponential growth of the neighborhood size,
we adopt a one-angle-exchange algorithm [104] in our approach. The beam angle set
in a neighborhood can have only one different beam compare to the central beam set
A¯. The neighborhood of A¯ is defined as
N(A¯) =
{
A¯′ : A¯′ = (A¯ ∪ {a′})\ {a}
}
, for a′ ∈ δ (a) , a ∈ A¯}, (5.13)
where δ (a) is a neighborhood of given beam angle a. The neighbor angles are defined
in the following sections according to specific requirement in different search level.
5.2.3.2 Cluster Level LNS
As the result of Section 5.2.2, the total candidate beam set (A) has been grouped
into M clusters and found a centroid beam angle for each cluster. We denote this
centroid beam angle set as AC , |AC | = M . Because the centroid beam angles are
representative angles of the total candidate beam angle set and M is typically much
smaller than N , our strategy is to determine the optimal solution A¯∗C with k beam
angles in the centroid beam angle set. This solution is sued as a starting point for
local adjustment to search for the final beam angle solution in the candidate beam
set.
In this step, we use LNS algorithm described in Section 5.2.3.1 to search for the
solution A¯∗C . To find the optimal solution, we define the neighbor angle set δ (a) is
80
the whole centroid angle set AC ,
δ (a) = {a : a ∈ AC} . (5.14)
Because the M  N , the cluster level LNS can still be solved in an acceptable time
even if the neighborhood includes all centroid angles. For example, a problem with
N = 36, M = 6 and k = 3. In worst case, cluster level enumerates all the 3 beam
angle combinations in set AC , the maximum iteration is C63 = 20. Although the
LNS algorithm cannot guarantee optimal, this neighborhood definition ensures the
algorithm can search a sufficient space to find the optimal solution or a solution very
close to the optimal in the centroid beam angle set.
5.2.3.3 SVM for Reducing Feasible Region
In the cluster level LNS, the solution is based solely on the selected centroid
beam angles. To explore a better solution, we need to perform another search in the
total candidate beams. However, commonly the number of candidate beams is much
larger than centroid beams. In this case, a preprocessing step is added to reduce the
search space based on the results of the cluster level LNS.
The SVM is a type of learning algorithm that is commonly used for classifica-
tion [105, 106]. Given a set of training data, labeled for belonging to one of two
categories, the algorithm outputs an optimal hyperplane that assigns new input data
into appropriate category.
In our study, the centroid beam angle set is used as the training data. For each
81
centroid angle, the sub-scores of each structure in nominal case are used as an input
example, it can be denoted as Ia =
{
S(a)nominalΩ Ω ∈ {T,O}
}
, a ∈ C. And the input
points are labeled by variable La, where the value was decided by to the solution A¯∗C
found in cluster level LNS. If the centroid angles belonging to the optimal solution in
the cluster level LNS (i.e., a ∈ A¯∗C), we set La = +1, otherwise, the beam angle was
labeled as La = −1. The decision function implemented by the SVM can be written
as
f(~I) = sgn
(∑
a
Laαa ·K
(
~I, ~Ia
)
+ β
)
, (5.15)
where K is a kernel function and the coefficients αa and β are determined by maxi-
mizing the following problem
max ∑
a
αa − 12
∑
a
∑
a′
αaαa′LaLaK
(
~Ia, ~Ia′
)
s.t. αa ≥ 0 and ∑
a
αaLa = 0
. (5.16)
The Radial Basic Function (RBF) kernel [107] is applied in our algorithm.
After SVN training, the rest of the non-centroid beam angles in candidate beam
angle set are classified. If a beam angle is classified as -1, it would be removed from
the final candidate beam angle set Af .
5.2.3.4 Candidate Beam Level LNS
We obtain a feasible solution A¯∗C and the final candidate beam angle set Af
from previous steps. In the last step, we perform another local neighborhood search
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to find the final solution. In this step, the initial beam angle set for LNS is the optimal
solution A¯∗C found in section 5.2.3.2. The local neighborhood δ (a) in candidate beams
is the angles geometrically located within a’s adjacent area. It is defined as
δ (a) = {a′ : a′ = [a− ε, a+ ε], for a′ ∈ Af and a′ /∈ A¯} mod 360◦,
(5.17)
where ε is a parameter that determines the size of δ (a), a larger ε represents a larger
neighborhood of the center angle. For example, for a beam angle with parameters
a = 0 and ε = 3, the neighborhood is {330,340,350,10,20,30}.
5.2.4 Patient Studies and Setup
The solution methods were tested on two lung cancer cases and two esophagus
cases. For all cases, 36 equispaced coplanar beam angles were considered as candidate
beam angles for selecting 3 beam angles, which are normally used in clinical treatment
planning. Table 5.1 shows the prescribed dose to the internal clinical target volume
(ICTV) for lung cases was 66 Gy and for esophageal cancer was set at 50.4 Gy. To
achieve a uniform dose, the penalty weight for target was set much higher than the
penalty of OARs. The numbers of voxels in major volumes of interest are listed in
Table 5.2. 4DCT was acquired for each case. The nominal dose was evaluated on the
average phase of the 4DCT (CTave) and the doses on the maximum inhale and exhale
phases (CT0 and CT50) were considered as uncertainty scenarios.
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Table 5.1: Prescriptions and penalty weights used for IMPT plan optimization.
Cancer Type Prescription (Gy) Structure Penalty
Lung 66 ICTV 100
Cord 1
Esophagus 1
Heart 1
Lung 1
Esophagus 50.4 ICTV 100
Cord 1
Esophagus 1
Heart 1
Lung 1
Table 5.2: Numberof voxels within each structures for different cases
Number of voxels
Case ICTV cord Esophagus Heart Lung
Lung I 9974 773 741 10874 65073
Lung II 4537 466 990 13939 89165
Esophageal I 2247 1143 352 5850 18472
Esophageal II 1343 510 392 7374 38538
In order to analyze the convergence properties, we implemented a standalone
LNS, a simulated annealing (SA) algorithm, a genetic algorithm (GA) and a hybrid
SA-LNS and a GA-LNS to compare with TSBAO method. Table 5.3 lists the stopping
criteria for all tested approaches. The neighborhood size ε = 3 was adopted for local
neighborhood search algorithm. For result analysis, we exhaustive enumerated all
3-beam combinations out of 36 candidate beams.
The proposed TSBAO method and all comparison algorithms were implemented
in C++ and GAMS. All computations in this study were performed on a 64-bit Linux
server with dual ten-core Intel Xeon 3 GHz processor and 364 GB memory.
In all plans the dose was normalized to 95% of ICTV receiving 100% of the
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Table 5.3: Stopping criteria for different BAO algorithms
Algorithm Stopping criteria
SA Number of iterations exceeds 500; orThese is no better solution found in 20 successive iterations
SA-LNS
SA: Number of iterations exceeds 100; or
These is no better solution found in 10 successive iterations
LNS: These is no better solution found in local neighborhood
GA Number of generations exceeds 50; orThese is no better solution found in 20 successive iterations
GA-LNS
GA: Number of generations exceeds 20; or
These is no better solution found in 10 successive iterations
LNS: These is no better solution found in local neighborhood
LNS These is no better solution found in local neighborhood
TSBAO These is no better solution found in local neighborhood
prescribed dose. To evaluate the plan quality and robustness, we calculated the plan
on CTave, CT0 and CT50 to yield the corresponding doses DCTave, DCT0 and DCT50.
The 4D95 of ICTV, calculated based on max differences in D95 of ICTV between
dose scenarios, was used to quantify the overall plan robustness. A heterogeneity
index (HI) was computed for the ICTV to measure the dose uniformity. The HI was
defined as follows
HI = D5/D95, (5.18)
where D5 and D95 correspond to the doses delivered to 5% and 95% of ICTV, re-
spectively. A larger HI indicates a greater degree of dose heterogeneity. For normal
structures, cord maximum dose, esophagus V40 (i.e., the volume of esophagus re-
ceived at least 40 Gy dose) and V50, heart V30 and V40, lung V5, V20 and mean
dose were evaluated.
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5.3 Results
Figure 5.2 shows the beam angle score as a function of beam angle for lung
case I. The centroids selected by p-median clustering for this case are indicated with
triangle. It demonstrates that the clustering algorithm attempted to find the beam
angles with local minimum scores as centroids. And all the centroids are kept away
from each other. Total 6 beam clusters were grouped for this case. The beam angle
with a local minimum beam score is prone to be selected as the centroid of the cluster.
Figure 5.2: Beam angle score of 36 candidate beam angles (dotted line), the centroid beam
angles (triangle) and the solution found by cluster level LNS (black dot) for
lung case I.
To investigate which beam angle is more preferred to be selected in high quality
IMPT plans, we optimized IMPT plans for all possible combinations of 3 beams out
of a pool of 36 equispaced coplanar beams. Based on the objective function value, the
best 200 (i.e., about 3% of total C363 = 7140 combinations) IMPT plans were selected
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for the analysis. Figure 5.3A shows the probability of beam angle appearance in the
best 200 IMPT plans for the lung case I. The beam angles 20 and 310 are two peaks
and their adjacent angles are most probable regions to be selected in the top quality
plans, while the beams from 90 to 200 are not preferred.
Figure 5.3: Beam angle appearance probability in the best 200 IMPT plans (A), and the
histogram of average beam angle appearance probability (B) for lung case I.
The beam angles in the solution of the cluster level LNS are 10, 260 and 310,
which is indicated in Figure 5.3 by black dot. And after SVM classification, the final
candidate beam angle set for the candidate beam level LNS is indicated by shadow-
covered area in Figure 5.3A, which includes angles 0-50 and 230-350. Around 81.5%
beams appeared in the best 200 plans are included in Af . All the high frequency
beams such as angle 20 and angle 310 are included in the final candidate beam set.
To analyze the relationship between the beam angle score and the appearance
probability, we plot the average beam angle appearance probability versus the beam
angle score for lung case I in Figure 5.3B. The beam angles are divided into several
groups according to their beam angle scores. The number of beam score interval is
87
calculated based on Sturges’ rule (I = 1+log2N). In our case N = 36, so the number
of interval is 7. The average appearance probability for SI, P¯(SI), is calculated as
P¯(SI) =
∑
S(a)∈SI
P(a)
NSI ,
(5.19)
where, P(a) is the appearance probability of beam angle a; NSI is the number of beam
angles with the beam angle score within a beam angle score interval. Empirically,
beam angles with a lower score are associated with a higher appearance probability
in the final treatment plan. It shows the effectiveness of beam angle score function.
However, due to our beam score is still based on individual beam, it cannot reflect
the potential of the beam be selected in good plans very precise. For example, the
appearance probability of a beam with score 0.0012 is lower than the beam with score
0.0013. Overall, there is a negative correlation between the beam angle score and the
appearance probability (blue dot trend line).
We applied the TSBAO to all test cases, the centroids of clusters and the final
solutions found by this method for all 4 tested cases are demonstrated in Figure 5.4.
For all cases, 6 or 7 clusters were estimated as a proper number by our algorithm.
The centroids distribution were {10,70,110,180,260,310}, {0,30,60,130,160,200,290}
for lung case I and II, and {0,90,150,190,240,300,330}, {10,40,90,190,230,290} for
esophageal case I and II, accordingly. The corresponding solutions found by TSBAO
were {20,260,320}, {200,270,350}, {90,200,290} and {20,180,300}, respectively. All
the beam angles in the final solutions were located on the centroid angle or very close
88
to the nearby centroid.
Figure 5.4: Centroid distributions and final solutions obtained by TSBAO method for 4
clinical cases. Centroids are denoted by dashed lines and TSBAO solutions
are solid lines.
In order to analyze the convergence rate of the TSBAO algorithm, we tracked
objective function values improving at each iteration until the algorithm terminates.
Figure 5.5 shows the progression of objective convergence for the TSBAO, standalone
LNS, SA, SA-LNS, GA and GA-LNS algorithms implemented on four tested patient
cases. Note that, globally optimal solutions were found by exhaustive search and also
shown by dashed-dotted lines in Figure 5.5. The figure demonstrated that TSBAO
method found global optimal solutions for Lung I, II and esophagus case I. Compared
to other algorithms, TSBAO method also converged closer to the global optimal for
the esophagus case II. From computational time aspect, TSBAO was also faster than
all heuristic and hybrid BAO algorithms and similar with single LNS algorithm. For
all cases, TSBAO spend 50-70 minutes consistently for all tested cases which was
around half of the time cost by SA, GA, SA-LNS and GA-LNS. For SA and GA,
the results varied case by case. And in general, these algorithms were hard to find
solutions close to the global optimal before they meet the stopping criteria. The
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hybrid algorithms, i.e., SA-LNS and GA-LNS, were better than standalone SA and
GA from both objective value and time spending point of view. The hybrid algorithms
also can find the solution close to the global optima. In tested cases, SA-LNS found
the global optimal for two lung cases. GA-LNS also found the global optimal for
Esophagus case I, and the result of Lung case II was very close to the global optima.
Figure 5.5: Converge comparison for TSBAO (solid lines), standalone LNS (dashed lines),
SA (cross solid lines), SA-LNS (triangle solid lines), GA (asterisk solid lines),
and GA-LNS (circle solid lines). Global optima are shown by dotted lines.
Table 5.4 lists the dose volume results obtained from the BAO solution methods
for four clinical cases. We can see from Table 5.4 that better target dose uniformity
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and robustness were achieved by TSBAO for all tested cases. However, for OAR
sparing the results varied case by case. TSBAO achieved best OAR sparing for
majority of indices of lung II and esophagus I. For lung case I and esophagus II, the
plans found by STBAO only achieve best lung sparing between all tested algorithms.
Figure 5.6 compare the beam angles selected under different solution methods
for the IMPT lung case I with 36-angle configuration. The global optimal solution for
this case was {20,260,320}. The TSBAO method found the global optimal in the end.
All other tested algorithms were starting at the equally spaced beam angles {0,120,24}
and the final results were significantly different between each other. Specifically, SA-
LNS also found the global optimal solution. The optimized beam angle configurations
showed that LNS algorithm was significantly influenced by its initial point. For
example, angles found by single LNS are {20,120,220}, which are close to the equal
spaced starting point. And for all hybrid algorithms (i.e., SA-LNS and GA-LNS), the
final solutions were also close to the results got from pure SA and GA. For example,
the solution of SA is {30,260,310} and the solution of SA-LNS is {20,260,320}.
5.4 Discussion
Different algorithms have been reported to solve the BAO problem in radiation
therapy, but these algorithms need a long time to find the solution or the performance
is influenced by starting point or input parameters. This paper, we focuses on a
two-stage BAO method which considering prior knowledge of beam information and
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Figure 5.6: Beam angle configurations selected for the Lung case I by different algorithms.
Equal spaced beam angles are denoted by dashed lines, the final solutions by
green solid lines and the optimal solution by red solid lines.
incorporating uncertainty of internal organ motion to solve the BAO problem in IMPT
treatment planning.
Uncertainty issue is a critical problem for IMPT treatment. In this work, to
tackle the internal motion during treatment, a 4D robust fluence model is used to
optimize the beamlet intensities. Furthermore, a beam angle score considering uncer-
tainty information is introduced for beam angle clustering to help the algorithm to
find the robust beam angle solutions. To our knowledge, it is the first work that incor-
porates uncertainty information as beam angle prior knowledge to guide beam angle
optimization for IMPT planning. A bi-level deterministic local neighborhood search
algorithm is used to improve the searching accuracy and reduce the total convergence
time. Comparing to stochastic global algorithms such as simulated annealing and
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genetic algorithm, we showed that the proposed clustering algorithm could greatly
reduce the searching time. And compared to simple local neighborhood search al-
gorithm, our algorithm can converge consistently to a good solution regardless of
starting point or parameter settings.
Although the TSBAO algorithm demonstrated good convergence properties, it
still does not guarantee global optimal. For example, in esophagus case II the objec-
tive value of global optimal is 4.73 while the solution found by clustering method is
4.80. Figure 5.7 shows the beam configurations of global optimal and solution found
by TSBAO method. The global optimal is 20,170,290 and the TSBAO solution is
20,180,300. Although the solution is very close, two of the beams different. Using the
one beam exchange local neighborhood search algorithm we cannot find the optimal
solution. So, how to define the neighborhood to balance the time and result quality
is still a problem for local neighborhood search algorithm for IMPT BAO.
Figure 5.7: Beam angle configurations found by cluster method and global optimal for
esophagus case II.
In this study, we focus on the target dose coverage and robustness, the penalty
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weight of ICTV is much higher than that of OARs (i.e., 100:1). TSBAO achieved
best objective values for tested cases and the plans can yield the best dose uniformity
and robustness compare to other tested algorithms. However, these plans cannot
guarantee the best dose sparing for all ORAs (Figure 5.7). Because OAR sparing is
very sensitive to the beam angle incident direction, when there are multiple critical
organs surrounding the target, it is hard to find a beam angle set can yield best dose
sparing for all OARs at the same time, especially for IMPT treatment plan with much
fewer beam angles than IMRT plan. So, how to balance the weight between different
OARs is still depends on physicians or planners’ preference.
Up to now, in all prior knowledge guided BAO algorithm, the feasibility scores
are defined based on each standalone beam angle. This score definition cannot reflect
the fitness of treatment plan with multiple beams directly. So, in this work, we choose
using a cluster level LNS to find an optimal solution in centroid beam angles, so that
we can have a good starting point in global scale. This step helps the algorithm
avoid trapping in local minima. However, this step requires extra time for searching
the solution. If the cluster number is large, the time for the cluster level LNS may
increase rapidly. Therefore, how to find the correlation between beam angles in prior
knowledge, so that it can reflect the merit of beam in a treatment plan is still under
investigation.
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5.5 Conclusion
This study focuses on the BAO problem in IMPT treatment planning consid-
ering internal organ motion and using prior knowledge guidance. We introduced a
TSBAO method to beam angle optimization incorporating internal motion uncer-
tainty for IMPT treatment planning. First, a p-median method was used for beam
angle clustering. A beam angle score function incorporated uncertainty information
was introduced to measure the merit of a beam angle for beam angle clustering. Then,
a bi-LNS algorithm was designed to search the final solution for the treatment plan.
We have demonstrated the algorithm can consistently find the solution of global op-
timal or close to it on four thoracic cancer cases. The efficiency of this algorithm was
illustrated by comparing it with alternative BAO algorithms.
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Chapter 6
Summary and Future Work
6.1 Current Findings
Radiation therapy is one of the most common treatments for many types of
cancer. Different procedures of treatment planning can be formulated as different
optimization problems. In this dissertation, we investigated two major optimization
problems in intensity modulated proton therapy: fluence map optimization and beam
angle optimization. Furthermore, we proposed a new robust optimization method to
handle the misalignment error in multi-isocenter large field treatment planning.
Chapter 3 of the dissertation concentrated on solving the fluence map optimiza-
tion problem. We found the conventional optimization algorithms require consider-
able long time or the performance is influenced by initial starting points. To overcome
such shortcomings, we proposed a molecular dynamics method as a new alternative
for solving the FMO problem in IMPT. We applied this method on three clinical can-
cer cases and compared the performance with three literature reported algorithms.
We demonstrated that the MD method consistently performs better than other well-
accepted methods, such as quasi-Newton, LBFGS and LBFGS-B, in both objective
value and computational time.
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Chapter 4 addressed the misalignment uncertainty issue in treating patients
with large tumor size and require multi-isocenter large field treatment plan. Conven-
tional, it requires complex treatment planning procedures for this type of patient. We
proposed and validated a robust optimization approach to incorporate misalignment
uncertainty into intensity modulated proton therapy treatment planning. The results
demonstrated that the robust optimized IMPT treatment plan yields a low-gradient
field dose in the junction regions to minimize the impact caused by misalignment
errors. This method can greatly improve treatment planning efficiency and patient
safety.
In Chapter 5, we focus on solving the beam angle selection problem in intensity
modulated proton therapy. Beam angle optimization problem is NP hard. Con-
ventional the global BAO methods require a long time to solve the problem and
the performance is influenced by parameters used. The performance of local search
methods highly depends on the starting point. Furthermore, the proton therapy is
very sensitive to uncertainties, especially the large internal organ motion during the
treatment. If considering the uncertainties into the BAO problem, it will increase a
considerable computational time to solve. In order to find reliable solutions in a rela-
tively short time, we developed a two-stage robust beam angle optimization method
for the IMPT beam angle optimization. In this approach, we introduced a beam angle
score function using the prior knowledge to incorporating the internal organ motion
to measure the merit of beam angles. A p-median algorithm is developed for beam
angle clustering to guide the beam angle searching. A bi-level local neighborhood
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search algorithm is used to determine the final beam angle set for the treatment.
Furthermore, Support vector machine (SVM) is used in bi-level LNS to reduce the
search space. Our methods were tested on four thoracic cancer cases. It demonstrates
that the two-stage method outperformed five widely used beam angle optimization
methods, including a standalone LNS, simulated annealing (SA), genetic algorithms
(GA), hybrid SA-LNS and hybrid GA-LNS in both objective value and CPU time.
6.2 Future Work
The molecular dynamics method is well accepted to solve the problem in mate-
rial science. This method is a good candidate to be parallelized for running on the
multi-core workstation. Based on the current progress, develop a parallel MD method
for fluence map optimization can greatly improve the speed of the solving the prob-
lem. In addition, different parallel strategies can be investigated. Incorporating the
uncertainty into the MD method can be another direction for the future work.
In our study, the two-stage beam angle optimization method has two hypothesis,
one is the candidate beam angle set is finite and another one is the number of beam
angles for treatment is given by planner. Now, the beam angle number is still decided
by planner based on their experience. So, To estimate the optimum number of beams
for IMPT treatment plan is an important topic for beam angle selection problem.
Up to now, the beam angle scoring is only based on the information of one indi-
vidual beam angle, this score can only measure the merit of a single beam. However,
a whole treatment plan consists of multiple beams, the beam angle score is hard to
99
correctly reflect whether this beam can collaborate with other beams to generate a
high-quality plan. So, To consider the correlation between beam angles for beam
angle scoring is the next step of our research.
Along with the patient case increasing, the proved high-quality treatment plan
can be used as a database. Patient geometric information, beam angle setup and
optimization parameters can be fully investigated. Various solution techniques, such
as data mining or statistical inference, can be applied to identify the relationships
between different patients. The stored beam angle sets and parameter sets can be
suggested for the new patient case. At least, it can offer a good starting point for
treatment plan optimization to improve the efficiency.
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Appendix
Figure 1: Dose-volume histogram comparison for the head-and-neck case.
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Figure 2: Dose-volume histogram comparison for the lung case.
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Figure 3: The OFVs as a function of time for the optimization processes for the head-
and-neck case starting from FW, IW and SOBP using quasi-Newton, L-BFGS,
L-BFGS-B and the MD method.
Figure 4: The OFVs as a function of time for the optimization processes for the lung case
starting from FW, IW and SOBP using quasi-Newton, L-BFGS, L-BFGS-B and
the MD method.
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